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Abstract 
GCN4 is a transcriptional activatory protein found in S. cerevisiae and is 
a member of the basic region leucine zipper (bZip) family of DNA.binding 
proteins. The full length protein is 281 residues in length and consists of 
an activatory region and a DNA-binding region. The DNA-binding region 
of the protein consists of two separate regions; a leucine zipper through 
which the protein dimerises, and a basic region which contacts target 
DNA. Various studies have shown that it is possible to mutate residues in 
the basic region and create proteins with changed specificity. The aim of 
this project was to use XZAPII technology to create a large library of 
mutants and investigate the effects of single and double mutants in the 
basic region and linker segment of GCN4. 
The DNA-binding (bZip) region of GCN4 was extracted from a plasmid 
containing the entire GCN4 géné and cloned into the lacZ gene-- of the 
bacteriophage vector XZA.PII. The recombinant vector was infected into a 
strain of E. coli which allowed the bZip gene to be expressed as a fusion 
protein with -galactosidase. In vitro screening experiments were carried 
out and any 'positive' clones which bound to a DNA target identified. The 
DNA sequence of each positive clone was then determined. These 
experiments demonstrated that the 7ZAPII system was an excellent 
vehicle for the expression and identification of a DNA library and that 
identical conditions could be used to screen a large library of mutants. 
A phagemid containing the bZip gene was excised from 22APII in vivo 
and infected into E. coli. These cells were used to overexpress the - 
galactosidase-bZip fusion protein. The fusion protein was purified and 
shown to bind with high affinity to a specific DNA target. 
Single-stranded phagemid DNA was prepared in vivo and used as a 
template to attempt in vitro mutagenesis across a large portion of the 
GCN4 basic region via phosphorothioate based spiked mutagenesis. 
111 
ABBREVIATIONS 
ATF activating transcription factor 
bZip basic region leucine zipper 
CD circular dichroism 
C/EBP CAAT-box enhancer binding protein 
CREB cyclic-AMP response element binding site/protein 
dNTP deoxynucleotide triphosphate 
GCN4 general control non-derepressable 4 
HEPES N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulphonic acid) 
IPTG isopropyithiogalactoside 
LMP low melting point 
NMR nuclear magnetic resonance 
PCR polymerase chain reaction 
RF replicative form 
TAF- 1 	transcriptional activatory factor-1 
TBP transcription factor binding protein 
TFII(A-H) 	transcription factor II (A-H) 
Tris 	tris(hydroxymethyl)aminomethane 
X-gal 5-bromo-4-chloro-3-indolyl- 3-D-galactoside 
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1.1 TRANSCRIPTIONAL REGULATION. 
In eukaryotic organisms, initiation and regulation of transcription is 
dependant on the interaction of several proteins with the promoter 
elements of DNA. RNA polymerase II (pol II), which is sufficient to 
initiate transcription in prokaryotes, cannot initiate transcription alone 
and is reliant on a number of other proteins known as transcripton 
factors 1 . 
Genes to be regulated contain promoter sequences which are composed, in 
general, of TATA and initiator elements. These elements are necessary 
for the initiation and accuracy of transcription. The regulation of genes 
- - 	- 	may also be affected by sequences known as enhancers, which can act at - 
great distances from the promoter elements. In yeast, sequences known 
as upstream activator sequences (UAS), which have an analogous 
function, are present 2 . 
Initiation of transcription occurs when a complex of initiation factors is 
formed on the TATA box. Initially, TFIID is bound to the TATA element 
of the promoter. This complex, which also consists of TBP and the TBP -
associated factors (TAF's), acts as a binding site for TFIIB. Pol II and 
TFIIF are then recruited into the complex. To complete formation of the 
initiation complex TFIIE and TFIIH become associated and transcription 
may occur 3 ' 4 (Fig.1.1). 
The rate of transcription may be regulated by additional transcription 
regulatory proteins which recognise specific DNA sequences within 
enhancer or UAS elements. These proteins may then participate in highly 
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Transcription factors are represented by their letter designations. The bold line 
represents the promoter DNA while the bent arrow indicates the initiation site. Double-
headed arrows indicate protein-protein interactions. 
Fig. 1.1. Transcription Initiation Complex Assembly. 
These transcriptional regulatory proteins invariably consist of two 
distinct regions; an activation domain and a DNA-binding domain. 
Several types of activation domains have been identified and classified on 
the basis of their amino acid composition as acidic, glutamine rich and 
proline rich7 ' 8 . These domains may be relatively short and are often 
unstructured. A structural change my occur, however, upon association 
with one or more of the components of the initiation complex. 
Structural and sequence comparisons of transcriptional regulatory 
proteins have revealed that the DNA-binding domains of many of these 
proteins form similar three dimensional structures. Studies have shown 
that it is possible to classify certain proteins according to their shape. As 
a result several structural families have been described whereby each-. -. 
member forms the distinct shape or motif of that family. Each of these 
motifs involves one or more units of secondary structure (usually an a- 
helix) that are complementary to the structure of B-DNA. 
4 
1.2 DNA BINDING MOTIFS. 
The structure of numerous transcriptional regulatory proteins have been 
determined. In this introduction, I have attempted to give an overveiw of 
the best characterised DNA-binding motifs. 
Several excellent reviews have been published which give an insight into 
the various structures adopted by these proteins 9 ' 10' 11 . 
1.3 THE HELIX-TURN-HELIX MOTIF. 
The helix-turn-helix (HTH) motif was the first DNA-recognition motif 
discôvered12' i3  Most of the prokaryotic regulatory proteins -belong to-this - --
group. Many protein structures containing the HTH motif have been 
solved by X-ray crystallography and NMR, including those of ? Cro 
protein, X repressor and the trp repressor 14,15,16,17,18 .  
The HTH is generally defined as a 20-residue segment, with two a-helices 
that cross at an angle of about 120 0. Additional helical residues may also 
be present at the N-terminus of the first helix or the C-terminus of the 
second. The HTH (unlike many other motifs) is not a separate, stable 
domain. It cannot fold or function by itself, but always occurs as part of a 
larger DNA-binding domain. 
Comparisons of HTH protein-DNA complexes have shown that a number 
of common features exist. Repressor proteins bind to DNA as dimers with 
each monomer recognising a half-site. The first helix of the HTH unit 
does not contact the DNA, but the N-terminus of this helix contacts the 
DNA backbone. The second helix, however, fits into the major groove with 
the N-terminal portion being closest to the edges of the base pairs. Site-
specific contacts with bases in the major groove are made by amino acid 
side-chains. Recognition is also acheived via a network of hydrogen bonds 
between the protein and the DNA backbone (Fig. 1.2). 
Fig.1.2. Schematic representation of a HTH-DNA complex. 
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1.4 HOMEODOMAINS. 
Homeodomains are 60 amino acid DNA-binding domains which consist of 
three a-helices and an amino-terminal arm 19. Structural studies of 
various homeodomains have shown that they contain a HTH motif. 
However, unlike the HTH, the 60-residue homeodomain forms a stable, 
folded structure and can bind to DNA as a monomer by itself. 
The structures of the various homeodomains are very similar. Helix 1 and 
helix 2 pack against each other in an antiparallel arrangement, with 
helix 3 roughly perpendicular to them. The hydrophobic face of helix 3 
packs against helices 1 and 2 to form the interior of the domain (Fig. 1.3). 
Contacts with DNA are made by residues of helix 3, which fits into- the 
major groove, and by residues in the extended N-terminal arm, which fits 
into the minor groove. Comparison of two homeodomains, MATcx2 and the 
engrailed homeodomain, shows that the contacts made between the 
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Fig. 1.3. Schematic representation of a homeodomain-DNA complex. 
1.5 ZINC BINDING DOMAINS. 
Three classes of zinc binding domains have been identified, each with a 
different structure 22. The first (Type I) is the original "Zn finger" which is 
a 30-residue peptide with two cysteines and two histidines coordinated to 
one Zn2 ion23. These proteins usually contain the sequence pattern 
Cys-X204-Cys-X 12-His-X35-His 
The majority of proteins containing these units have three or more 
fingers in direct succession. The basic structure consists of a 12-residue a-
helix packed against a n-hairpin. Both the cysteines flank the turn in the 
hairpin, and the two Zn-binding histiclines are on the inward facing side 
of the helix. This structure serves to hold the P sheet and the a-helix - 
together to form a compact globular domain (Fig. 1.4). 
The second type of Zn-binding domain (Type II) contains two loop-helix 
elements, each with a Zn 2 ion liganded by two cysteines at the beginning 
of the loop and two others at the N-terminus of the a-helix 24. The helices 
are packed against each other at approximately 90 0. DNA-binding 
specificity is determined by residues near the N-terminus which he in the 
major groove. Unlike the classical Zn finger, these proteins bind to DNA 
as dimers with residues at the beginning of the second loop responsible 
for dimerisation (Fig.1.4). 
The final class of Zn-binding domain (Type III) has only been found in 
yeast. The most studied of these proteins is GAL4 25. The DNA-binding 
domain of GAL4 is comprised of the 65 amino-terminal residues. This 
region of the protein retains its ability to diinerise and bind to DNA upon 
isolation from the intact protein. The core of the DNA-binding domain is 
folded around two Zn 2 ions which are tetrahedrally coordinated by six 
cysteine residues, forming what is known as a 'binuclear cluster'. The 
metal binding domain mediates sequence-specific contacts by insertion of 
each monomer into the major groove on opposite faces of the DNA. The 
carboxy-terminal residues of each monomer form a two-stranded coiled-














N 	 / 	 - 
8 	
40 	 486 496 
470 
446 - 	461 
N 
49 
64 	 Type II 
Type III 
Fig.1.4. Zinc binding domains 
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1.6 BASIC REGION LEUCINE ZIPPER PROTEINS. 
One of the most recently discovered, and intensely studied, DNA-binding 
motifs is the basic region leucine zipper (bZip) motif26. Several excellent 
reviews describing its dimerisation and DNA-binding properties have 
been published27 '28 ' 29 ' 30 . 
1.6.1 Background. 
Comparison of the amino acid sequences of a variety of bZip proteins 
shows that the DNA-binding domain of these proteins consists of two 
regions, the leucine zipper and basic -region, - which have distinct - 
characteristics (Fig. 1.5). 
BASIC REGION 	 LEUCINE ZIPPER 
GCN4 	DPAALKRARNTEAARRSRARKLQRNKQLEDKVEELLSKNYHLENEVARLKKLVGER 
cJun LKRE IRLMKNREAARECRRKKKEYVKCLEEKVKTLKAQNSELASTANHLREQVAQL 
cFos 	EKRRIRRERNKMAAAKCRNRRRELTDTLQAETDQLEDEKSALQTE IANLLKEKEKL 
CREB RKREVRLMKNREAARECRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCHK 
C /EBP 	NEYRVRRERNIAVRKSRDKAKQRNVETQQKVLELTSDNDRLRKRVEQLSRELDTL 
ATF -1 LKRE IRLMKNREAARECRRKXKEYVKCIENRVAVLENQNKTLIEELKTLKDLYSNK 
Fig.1.5. bZip amino acid sequences. 
The leucine zipper region is characterised by the presence of a heptad 
repeat of leucine residues which are strongly conserved throughout the 
bZip family. Amino acids which face the dimerisation interface are more 
strongly conserved between closely related family members than amino 
acids that face away from the interface. The basic region is characterised 
by the presence of an abundance of basic amino acids several of which are 
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highly conserved within the bZip family of proteins. For example, an 
asparagine, two consecutive alanine residues and a cysteine or serine are 
conserved in the centre of the basic region. An invariant arginine and 
several conserved basic residues flank these neutral amino acids. The 
spacing between these amino acids is identical among virtually all 
proteins of the bZip family. 
The role of each of the regions has been investigated in a number of 
studies. The leucine zipper model, described below, suggested that the 
leucine zipper was responsible for dimerisation of the bZip protein which 
allowed the dimeric protein to interact with its target DNA in some 
way31 . Various studies involving molecular biological techniques have 
addressed the function of each of these regions. Experiments carried out - - 
by Kouzarides et al investigating the Fos-Jun heterodimer suggested that 
these regions were functionally very different 32. Mutagenesis of the 
leucine residues of both Fos and Jun eliminated dimerisation indicating 
that the residues in this region were necessary for dimerisation. 
Mutations in the basic region, meanwhile, were shown to abolish DNA-
binding of the heterodimer suggesting that the basic region interacted 
with DNA in some way. Further experiments involving mutagenesis, this 
time of the Fos leucine zipper and basic region, indicated the importance 
of the leucine zipper for dimer formation 33. In this case it was 
demonstrated that mutants in the basic region did not disrupt the 
dimerisation of the proteins, but did affect DNA-binding indicating that 
the presence of the leucine zipper was soley for the purpose of forming 
dimers. A model was proposed whereby Fos and Jun complexed through 
the leucine zipper with each monomer interacting with one half-site of 
the palindromic DNA. 
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Domain swap experiments also hinted at the nature of the leucine zipper 
and basic region. One of the first studies was carried out by Sellers et al 
who generated chimeras between GCN4 and Fos 34. The ability of the Fos-
Jun complex and the GCN4 homodimer to bind to the same DNA-binding 
site was exploited to show that a chimeric protein consisting of the 
leucine zipper of GCN4 fused to the Fos basic region was able to dimerise 
not only with itself but also GCN4. Both these complexes were capable of 
binding to the same DNA target. Similar experiments involved the 
generation of chimeras between GCN4 and C/EBP 35. The results of these 
experiments showed that the chimeras were able to homodimerise and 
bind to the target DNA specified by the basic region of the chimera. Both 
of these studies demonstrated the ability of the leucine zipper to confer - 
dimerisation autonomously upon bZip proteins allowing the basic region 
to interact with DNA and determine the binding specificity. 
1.6.2 The leucine zipper. 
The structure of bZip proteins was first addressed by Landschultz and co-
workers who termed the motif the leucine zipper 31 . By projecting the 
amino acid sequence of the rat liver protein CIEBP onto an idealised a-
helix they were able to show that a 28 ammo acid segment of the DNA-
binding domain exhibited considerable amphipathy. This model showed 
that one side of the a-helix was composed predominantly of hydrophobic 
residues with leucine residues appearing at every seventh position. The 
opposite face of the helix was shown to consist mainly of amino acids with 
charged and polar side chains. Analysis of other proteins with significant 
sequence similarity such as GCN4, Fos, and Jun showed that segments 
within the DNA-binding domains of these proteins also formed 
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amphipathic a-helices when arranged on a helical wheel. Closer analysis 
of the model showed that the polar face of the amphipathic helix 
displayed charged residues configured in a manner which would allow 
salt bridge formation. This and the fact that the a-helices displayed a 
heptad repeat of leucine residues led the authors to postulate that these 
proteins formed a coiled-coil structure which is commonly found in fibrous 
proteins36. Using computer modelling the authors argued that the leucine 
residues of one protein monomer would be able to interdigitate with those 
of another in a parallel or antiparallel manner, although an antiparallel 
conformation was the favoured possibility. 
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Fig.1.6. Leucine zipper amino acid sequences. 
The structure of the leucine zipper region was refined in a number of 
later studies. Experiments by Gentz et al, who employed mutagenesis to 
study both the leucine zipper and the basic region of the oncoproteins Fos 
and Jun, indicated that the orientation of the a-helices in the Fos-Jun 
heterodimer was in fact parallel 37 . Study of the leucine zipper of GCN4 
using CD also suggested that the leucine zipper dimer formed a coiled-coil 
of parallel a-helices 38 . Both studies presented evidence which suggested 
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that it was unlikely that the leucine zipper was formed via interdigitation 
of leucine residues (Fig.1.7). 
iaT 
c. ;\ 
Fig.1.7. Interdigitation versus knobs into holes association. 
It was noted in both studies that the association of a-helices in a typical 
coiled-coil was not the result of interdigitation, but via a "knobs into 
holes" association created by hydrophobic interactions occurring at the 4, 
3 positions of each helix. This model was first proposed by Crick who 
realised that the structure of a coiled-coil could be stabilised by the 
packing of the hydrophobic side-chains of one helix into the spaces 
created between the side-chains of the neighbouring helix 36. The pattern 
of residues in a coiled-coil may be described as (abcdefg) whereby 
residues at positions a and d fall on the same face of an a-helix. 
Oppositely charged residues often occur at positions e and g of adjacent 
heptads allowing the formation of interhelical ion pairs. Comparison of 
the sequences of GCN4, Jun and C/EBP showed that the leucine zipper 
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region contained hydrophobic residues spaced every four and then three 
residues apart which was consistent with this model (Fig. 1.6). 
ld 	2d d 	4d 5d 
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Fig. 1.8. Coiled-coil packing interactions. 
Physical experiments involving the use of NMR indicated that the leucine 
zipper region of GCN4 was a-helical 39 . The symmetrical nature of the 
spectra obtained suggested that the structure of the leucine zipper was 
that of a parallel coiled-coil. Exchange data suggested that certain 
residues such as val-257, leu-260, leu-261, ala-272, leu-274, lys-275, lys- 
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276, leu-277, val-278, and glu-279 were shielded from solvent indicating 
that these residues formed the hydrophobic core of the coiled-coil. 
The structure of the leucine zipper region was finally elucidated with the 
publication of the X-ray structure of the GCN4 leucine zipper 40 (Fig.1.8). 
The study, whose results had been suggested by previous experiments, 
shows that the leucine zipper of GCN4 does in fact form a parallel coiled-
coil41 . The structure shows that the conserved leucines do not 
interdigitate as proposed in the original leucine zipper model. Instead it 
can be seen that the leucines and the amino acids in position a are 
surrounded by four residues from the neighbouring helix. Each leucine at 
position d packs against both the symmetry-related leucine (d') and the 
side chain of the following residue (g'). These two types of layer alternate 
through the structure to form the hydrophobic interface between each a- 
helix. 
The presence of interhelical ion pairs is suggested by distance 
calculations which indicate that salt bridge formation can occur between 
residues at position g of one heptad and position e' of the following 
heptad in the neighbouring helix. 
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Fig. 1.9. The GCN4 leucine zipper viewed along the coiled-coil axis. 
Fig.1.10. The GCN4 leucine zipper viewed down the coiled-coil axis. 
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1.6.3 Dimerisation specificity. 
Comparison of the leucine zipper sequences of various bZip proteins 
shows that there are number of common features (Fig.1.6). A variety of 
hydrophobic residues are found at positions a and d. Closer inspection 
reveals that the most favoured residue at position d is leucine, while 3-
branched amino acids often occur at the a position. Polar residues are 
usually found at the b, c, e, f, and g positions. Asparagine in the central 
heptad is common, while residues at positions e and g are often 
oppositely charged. This configuration of amino acids gives each heptad a 
characterstic (H.P.P.H.P.P.P) pattern, where H represents a 
hydrophobic residue and P a polar residue. The helices supercoil in a 
manner which places the hydrophobic residues on one side of the a-helix. 
I 
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Fig. 1.11. The GCN4 dimer helical wheel. 
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Single substitutions of residues at positions a and d can be made which 
do not alter the dimerisation specificity of the GCN4 leucine zipper 42 '43 . 
It is possible to incorporate a wide variety of amino acids, including basic 
and acidic residues, at the d positions. However, substitution of two or 
more leucines at the d positions results in reduction or elimination of 
dimerisation42 '43 . The presence of leucine at postion d appears to 
maximise the stability of the bZip dimer in some way. 
Although there is a marked conservation between the leucine zipper 
sequences within the bZip family, these proteins may associate as 
homodimers or heterodimers. Evidence suggests that residues e and g of 
the heptad repeats are of particular importance in influencing the 
dimerisation properties of certain bZip coiled-coils 44 '45 . 
Perhaps the most well characterised of the heterodimeric bZip proteins is 
the Fos-Jun heterodimer (Fig. 1.12). The Fos leucine zipper is very acidic, 
with a preponderance of acidic residues at positions e, g, and b. The 
leucine zipper of Jun, on the other hand, has a net positive charge due to 
the presence of basic amino acids at positions e and g. Studies have 
shown that the amino acids at these positions appear to influence 
whether each of these proteins will homodimerise or heterodimerise 46 . 
Experiments involving peptides have demonstrated that hybrid peptides 
containing the residues of Fos at the e and g positions are unable to 
associate, while the corresponding peptide containing Jun residues at 
these positions homodimerises and also heterodimerises with the Fos 
hybrids44. These results suggest that electrostatic attraction and 
repulsion between residues in these postions is a major determinant of 
the dimerisation state of Fos and Jun. Subsequent studies have 
demonstrated that a hybrid protein containing residues g1 and e2 of Fos, 
and a hybrid protein containing residues g1 and e2 of Jun is able to 
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heterodimerise, indicating that the electrostatic attraction between 
residues g and e is important in conferring heterodimerisation to these 
proteins45. Further experiments suggested that heterodimer formation 
was predominantly driven by destabilisation of Fos homodimers as a 
result of unfavourable electrostatic interactions at the e and g positions. 
The presence of these interhelical electrostatic interactions has been 
demonstrated in the X-ray structure of the Fos-Jun-DNA complex 48 . 
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Fig.1.12. Fos-Jun and Jun-Jun helical wheels. 
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The tendency of salt-bridges to be formed between the e and g residues in 
adjacent heptad repeats was also noted by Vinson and co-workers 49. They 
noted that two interhelical salt-bridges between residues in positions e 
and g were possible; one between the g of one helix and the e' of the 
other, the second between the e position of one helix and the g' of the 
opposing helix. These interactions were termed i+5 and 1+2 salt bridges 
respectively (Fig.1.13). This 'salt-bridge rule' was used to design novel 
peptides, based on C/EBP, which would preferentially homo- or 
heterodimerise. Results showed that it was possible to predict how the 
leucine zipper regions of bZip proteins would associate simply by analysis 
of residues at positions e and g. It was proposed that the precise 
placement of these charged amino acids was of critical importance in 	- 
determining whether a bZip leucine zipper would homo- or 
heterodimerise, or both. 
je f"bCF  je fgJb c 
A  
i+5 	i+2 
Fig.1.13. Salt bridges. 
A thermodynamic scale determining the stability of the commonly 
occuring e to g interhelical ion-pairs was subsequently proposed 50. The 
four most commonly occuring residues at the e and g positions of bZip 
proteins are lysine, arginine, glutamine, and glutamic acid. Thermal 
melting experiments suggested that the most stable helical pair occurred 
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between glutamic acid in the e position and arginine in the following g' 
position. 
Complementary evidence has also been presented which suggests that 
the dimerisation properties of a given coiled-coil cannot be predicted 
solely on the basis of the interactions between e and g residues. A study 
employing combinatorial mutagenesis of residues at these positions in the 
GCN4 leucine zipper suggested that favourable charge-charge 
interactions are not required to form stable leucine zippers 47 
In an exhaustive study employing random selection, Pu et al generated a 
library of leucine zippers which were capable of forming homo- and 
heterodimers 52 . It was found that a diverse set of zippers were capable of 
forming homo- or heterodirners, and that charged residues were not 
essential for dimer stability. These results suggested that the factors 
governing the formation of homo- and heterodimers are complex. 
The residues on the inside positions of bZip coiled-coils also affect the 
orientation of the a-helices and the oligomerisation state of a coiled-coil. 
A study investigating the orientation of the a-helices in two-stranded 
coiled-coils focussed on the function of residues at the e and g positions 53. 
It was shown that attractive and repulsive interactions were of particular 
importance in determining helical orientation. As in the Fos-Jun 
heterodimer, attractive interactions between residues e and g seem to be 
of particular importance in parallel coiled-coil formation. If the attractive 
interactions occur between positions g and g' or e and e' then an 
antiparallel coiled-coil is the favoured product. Ion-pairing between e and 
g residues of a GCN4-lac repressor hybrid has also been shown to be a 
major determinant in the formation of parallel two-stranded coiled-
coils54. 
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Changing the a and d positions of the GCN4 leucine zipper can alter the 
oligomerisation state remarkably. Harbury et al have recently shown that 
replacing these residues with combinations of leucine, valine, or 
isoleucine results in dimeric, trimeric or tetrameric proteins 55. A peptide 
containing isoleucine in the a positions exhibited a parallel two-stranded 
conformation, while a peptide containing isoleucine at all a and d 
positions formed parallel trimers. The X-ray structure of the isoleucine 
trimer showed that the three a-helical peptide monomers wrapped in a 
gradual left-handed superhelix with the isoleucine residues pointing into 
the core of the trimer 56. The individual a-helices appeared to be virtually 
identical to the GCN4 dimer on a local scale. 
A peptide containing leucine at all a positions and isoleucine at all d 
positions oligomerised as a parallel four-helical bundle. The X-ray 
structure showed that the four a-helices wrapped in a left-handed 
superhelix. As in the dimeric and trimeric structures the leucine and 
isoleucine side-chains at the a and d positions point into the centre of the 
structure. 
The X-ray structures of each of the oligomers show that interhelical ion-
pairs exist between the e and g residues of each helix. However, other 
salt-bridges are present in the tetramer between positions g to b and c to 
e. Each of the X-ray structures also shows that different 'knobs-into-holes' 
packing interactions occur. This pattern is reflected in the amino acid 
preference of each structure. In dimers, the a positions are populated 
with n-branched residues, whereas n-branched residues are disfavoured 
at the d positions. The presence of n-branched residues at both a and d 
positions favours trimer formation, while n-branched residues at the a 
positions disfavours tetramers. 
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1.6.4 The DNA-binding region. 
In the absence of an X-ray or detailed NMR structure the mode of binding 
of bZip proteins to DNA was predicted using computer modelling 
techniques. The first model to propose a structure for the bZip-DNA 
complex was described by Vinson and co-workers, who termed their model 
the "scissors-grip" model57. The primary feature of this model, which was 
based on the protein CIEBP, was the presence of a coiled-coil in the 
leucine zipper region which allowed the dimer to align itself at the centre 
of the dyad axis of a palindromic DNA target. This left the basic region of 
each monomer free to track along the major groove of the B-form DNA 
generating base-specific contacts. 
Sequence information was used to predict that the basic region formed an 
a-helix. However, it was suggested that the basic region would only 
become a-helical upon association with specific DNA. 
The key feature of this model was the proposal that the basic region did 
not form a continuous a-helix when bound to DNA. Instead, it was 
suggested that a kink was formed at the invariant asparagine, via a 
structure known as an N-cap, which bent the a-helices towards the DNA 
allowing additional contacts58. Specific amino acid side-chain contacts 
with DNA were not predicted. However, the idea was suggested that the 
positively charged side-chains of the conserved basic residues could be 
arranged in a manner which would allow complementary interaction with 
the negatively charged phosphodiester backbone. 
A second, more detailed, model which used footprinting and CD 
experiments as well as previous experimental evidence was proposed by 
O'Neil et a126. The model, known as the "induced-fork", was based on 
GCN4 and was in general agreement with the structure of the complex 
25 
proposed by Vinson et al. The model proposed that the leucine zipper of 
GCN4 also formed a coiled-coil structure which positioned the protein on 
the centre of the DNA recognition site allowing the arms of the basic 
region to make sequence specific contacts with the DNA bases in the 
major groove (Fig.1.16). 
CD experiments were performed which suggested that the helicity of the 
basic region increased in the presence of specific DNA. The results of 
these experiments were used to predict that, unlike in the scissors-grip 
model, the basic region of the protein was entirely a-helical with no 
kinks. This view directly conflicted with the structure predicted 
previously and suggested that the region of the basic region involved in 
DNA contact was considerably smaller than in the scissors-grip model. 
GCN4 D PAALKRARNTEAARR S RARKLQRMKQL 
ATF-]. LKREIRLMKNREAARECRRKKKEYVKCL 
ATF-2 EKRRKVLERNRAAASRCRQKRKVWVQSL 
C/EBP NE YRVR RE RNN I AVR K S RD KAKQ RNVE T 
CREB RKREVRLMKNREAARE CRRKKKEYVKCL 
CREM RKRELRLMKNREAARE CRRKKKEYVKCL 
cFos EKRR I RRERNKMAAAKCRNRRRELTDTL 
cJun I KAERKRMRNR IAAS KCRKRKLER IARL 
JunB IKVERKRLRNRLAATKCRKRKLERIARL 
Fig.1.15. Basic region amino acid sequences. 
Perhaps the most striking feature of the induced-fork model was the 
prediction of the amino acids involved in DNA contact. comparison of the 
amino acid sequences of a variety of bZip proteins showed that four 
residues at the centre of the basic region were conserved throughout the 
bZip family. The authors postulated that the short side-chains of asn-18, 
ala-15, ala-14 and cys-11 could directly interact with the DNA bases of 
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the recognition site. The positively charged residues flanking this quartet 
were proposed to add additional stability to the complex via interactions 
with the phosphodiester backbone. These predictions were later 
substantiated with the publication of the X-ray structures of the GCN4-
DNA complexes and the Fos-Jun-AP-1 complex 48 ' 59 ' 60 . 
Fig.1.16. The induced fork model. 
Subsequent studies involving biological and physical techniques have 
added credence to both of the above models. Experiments performed by 
Oakley and co-workers confirmed that the basic region ci-helices of 
peptides based on GCN4 were located in the major groove of DNA 61 . This 
result, which was acheived using the technique of affinity cleavage, 
agreed with the evidence presented in both of the models. Similar results 
obtained using alkylation interference also suggested that the arms of the 
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basic region were located in the major groove of DNA 62. The pattern of 
interference demonstrated that the dimeric protein contacted the DNA 
target with two-fold symmetry. 
The helicity of the basic region was investigated in a number of studies. 
An ingenious study exploiting the preference of trypsin for unstructured 
protein showed that digestion of the CIEBP-DNA complex resulted in two 
fragments63. It was postulated that the basic region of C/EBP bound to 
the DNA in a manner that prevented proteolysis. This result was 
consistent with a-helical content suggesting that the basic region was 
entirely a-helical with no kinks. 
Physical evidence complementing these results was presented by Saudek 
et al who used NMR and CD to demonstrate that the basic region of 
GCN4 was likely to be entirely a-helical 64 . 
Further experiments involving NMR and CD suggested that a 
considerable conformational change occurred when GCN4 bound to 
DNA65. In the absence of DNA it was shown that the helical content of 
the peptide is approximately 70% which corresponds to 40-43 residues. 
NMR evidence suggested that most of this could be attributed to the 
leucine zipper region of the peptide. Upon addition of target DNA the 
helicity of the peptide was shown to be 95-100% indicating that the basic 
region of the peptide undergoes a considerable conformational change. A 
* study of the DNA-binding activity of Fos and Jun showed than these 
proteins also undergo a conformational change upon addition of target 
DNA indicating that the flexibility of the basic region is probably 
universal throughout the bZip family 66. Similar results were presented 
by O'Neil et al who postulated a series of conformational changes which 
accompanied DNA binding 67. In the absence of target DNA it was 
proposed that the basic regions of bZip proteins could adopt flexible non- 
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helical conformations that minimise any repulsive intramolecular 
electrostatic interactions between their positively charged side-chains. 
Addition of DNA could result in an electrostatic attraction between the 
protein and the DNA allowing a non-specific interaction between the 
basic region and the phosphodiester backbone. The strongly negative 
electrostatic potential created by the presence of the DNA could then 
induce a-helical conformation in the basic region which could be 
stabilised further by interactions with bases and the phosphodiester 
backbone. 
1.6.5 The DNA. 
bZip proteins bind to a wide variety of DNA sequences. However, despite 
this diversity, a number of common features exist between each DNA 
target. The dimeric nature of bZip proteins imposes a number of 
constraints upon the DNA recognition site. Each basic region tracks along 
the major groove in opposite directions, therefore binding sequences tend 
to be palindromic. These dyad-symmetric binding sites may be directly 
abutted, as in the CREB/ATF site, or overlapping, as in the AP-1 
site68 ' 69. The area of each basic region contacting the DNA is relatively 
small, therefore the target sequence is typically in the region of 8 to 10 
base-pairs. DNA sequences outside this target region may also play a 
small part in the binding of bZip proteins, however, mutation or deletion 
of base-pairs within this region can affect binding markedly 70 ' 71 ' 72 . 
The local conformation of unbound DNA is sequence dependent and is 
determined by the preferred stacking interactions between adjacent base 
pairs73. Although the predominant forms of DNA are A- and B-form, DNA 
can adopt conformations which are intermediate between these. These 
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intermediate forms may have an enlarged major groove which is more 
accessible to the recognition helices of DNA-binding proteins 74. The 
binding of proteins in the major groove may also be enhanced by bending 
of the DNA which may incline the base pairs towards amino acid side-
chains involved in making sequence specific contacts 73 . 
The APi-site. 
+4+3+2 +1 0 -1 -2 -3 -4 
A TGAC TCA T 
TAC TGAGTA 
-4 -3 -2 -1 0 +1 +2+3 +4 
The CREB/ATF site. 
+4 +3+2 +1 0 0 -1 -2 -3 4 
ATGACGTCAT 
T AC T GC AGT A 
4 -3 -2 -1 0 0 +1+2+3 +4 
Fig.1.17. The AP-1 and CREB/ATF DNA sequences. 
The AP-1 site is a target sequence for a number of bZip proteins 69. In the 
unbound state this sequence adopts a straight B-form conformation 75. In 
the bound state, however, the AP-1 site exhibits a variety of 
conformations which are stabilised by the bound protein 76. The binding of 
GCN4, for example, does not alter the conformation whereas the binding 
of the Jun homodimer and the Fos-Jun heterodimer bends the DNA 
significantly59 ' 77 . Phasing analysis has shown that the Jun homodimer 
bends the DNA towards the major groove, while the Fos-Jun heterodimer 
bends the DNA towards the minor groove, away from the leucine 
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zipper78. An exhaustive study of DNA-bending by Fos and Jun related 
proteins demonstrated that the AP-1 site can adopt a variety of 
conformations upon association with a given thmer 76. They demonstrated 
that the degree and direction of the protein-induced DNA-bending was 
dependent upon the basic region interacting with each DNA half-site. 
Protein-induced bending by bZip proteins has also been shown to occur at 
the CREB/ATF site 79. In the absence of protein, the CREB/ATF site is 
bent at angle of 110 towards the major groove 75. However, upon 
association with the bZip protein CRE-BP1 the DNA displays no 
curvature indicating that the DNA is bent towards the minor groove. 
Binding of GCN4 also appears to induce a very slight curvature of this 
sequence, this time towards the major groove 75 . 
The sequence of the basic region appears to be important in influencing 
the degree of DNA-bending by bZip proteins. Comparison of bZip proteins 
reveals that there is a correlation between basic region sequence and the 
direction of protein-induced bending 75. Residues at the very N-terminus 
of the basic region appear to be critical in this respect. Proteins inducing 
a minor groove bend contain three basic residues in this area of the basic 
region, whereas proteins that induce a major groove bend contain a 
pattern of charged and hydrophobic residues in these positions. 
Sequence specific binding of bZip proteins to their DNA targets is 
therefore dependent upon a number of factors. DNA bending influences 
the binding specificity and it may be stabilised or induced upon 
association with a protein. This conformational change creates the correct 
spatial relationship for interaction between amino acid side-chains and 
the DNA bases and phosphodiester backbone. This association is 
dependent upon both the flexibility of the DNA and the protein, as well as 




One of the most exhaustively studied members of the bZip family is the 
yeast transcriptional activator GCN4. GCN4 is a positive regulator of 30-
40 unlinked genes encoding enzymes of amino acid biosynthetic pathways 
in S. cerevisiae80 . GCN4 protein is synthesised only during conditions of 
amino acid deprivation via a novel translational control mechanism. The 
mechanism is complex and is thought to be mediated by 4 short open 
reading frames in the leader of GCN4 mRNA81 . Amino acid biosynthetic 
enzymes are therefore only induced where cells are starved for amino 
acids. Studies have shown that GCN4 stimulates transcription by binding 
to short nucleotide sequences present upstream from each gene under its 
control. 
The sequence of the GCN4 gene was published independently by two 
groups in 198482,83 . The amino acid sequence derived from this shows 
that the entire protein is 281 residues in length and that the carboxy -
terminal end of the protein, which is essential for regulatory function; is 
rich in basic residues. 
Analysis of truncated GCN4 proteins defined the regions of GCN4 
responsible for DNA-binding and transcriptional activation 84 (Fig.1.18). 
A series of N-terminally deleted proteins were generated and assayed for 
their ability to bind to the his3 DNA sequence84. Results demonstrated 
that the DNA-binding domain of GCN4 was contained entirely within the 
60 carboxy-terminal amino acids. Further experiments with C-terminally 
deleted Lex-GCN4 fusion proteins showed that a fully functional GCN4 
transcription region was located within the 125 N-terminal amino acids 
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of the native protem 84. A 19 amino acid segment (107 to 125) within this 
acidic region was identified which was critical for transcriptional 
activation in vivo. 
activation 	 DNA-binding 
	
NI 	M C 
1 	107 125 	 226 	 281 
Fig.1.18. Schematic representation of the GCN4 protein. 
The exact structure and function of the activation region is not known. 
Deletion studies have suggested that this region probably has no defined 
structure 85 . It is thought that the function of the activation region is to 
interact with one or more of the components of the preinitiation complex 
bound to the TATA box. Indeed, evidence has been presented which 
indicates that GCN4 is able to bind to Pol II in vitro86 . However, these 
results indicated that the DNA-binding region interacts independently 
with Pol II suggesting that the activation region is unlikely to be involved 
in this interaction. The activation region may, however, contact another 
component of the transcriptional machinery. 
The DNA-binding region of GCN4 has been studied intensively and it is 
the most well characterised of all the bZip proteins. The bZip region 
consists of residues 226 to 281. This region is able to fold independently 
from the rest of the protein and bind DNA. Like all bZip proteins this 
region consists of two distinct segments, a leucine zipper and a basic 
region, which perform separate functions 31 ' 34 ' 87. The leucine zipper 
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region, which consists of four heptad repeats, forms a homodimeric coiled-
coil and positions the bZip region correctly to bind DNA 3 ' (Fig.1.19). The 
region between the leucine zipper and the basic region is of critical 
importance for DNA binding. Deletion or addition of amino acids which 
distort the helical register abolish DNA binding 88. Mutations in this 
region also alter DNA recognition markedly 89 . The basic region of GCN4 
is involved in DNA recognition and numerous residues directly contact 
the DNA bases and phosphate backbone 59'60'90. Mutation of amino acids 
in this region can result in proteins with altered specificity. 
abcdefg 
226- D P A 
A L K R A R N 	BASIC 
T E A A R R S 	REGION 
R A R K L Q R 
M K Q L E D K 
V E E L L S K 	LEUCINE 
N Y H L E N E 	ZIPPER 
V A R L K K L 
V G E R -281 
Fig.1.19. The GCN4 bZip region amino acid sequence. 
Various studies have defined the sequences of the DNA targets bound by 
the bZip region of GCN4. Initial studies, carried out in vitro, identified 
that many yeast biosynthetic genes containing the core sequence 
TGACTC were bound by GCN4 91 . This study reinforced previous evidence 
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which had shown that GCN4 bound with high affinity to the his3 site 
containing the palindromic sequence TGACTCA 92. The optimal sequence 
for the binding of GCN4 was later defined as ATGACTCAT 93 (Fig.1.17). 
This palindromic sequence is known as the AP-1 site as it is also 
recognised by proteins of the AP-1 family of transcription factors 69. Later 
studies revealed that GCN4 has almost equal affinity for the fully 
symmetric CREB/ATF site, which contains an additional G.0 base pair at 
the centre 62  (Fig.1.17). GCN4 is unable, however, to bind to DNA targets 
containing a deletion at the central C.G base pair 92 . 
1.7.2 The GCN4 bZip region-DNA complex. 
The crystal structures of the GCN4 bZip region bound to both the AP-1 
site and the ATF/CREB site have recently been published 59 '60 . The 
structures of both complexes are very similar and confirm much of the 
experimental evidence mentioned previously. 
Each structure shows that the dimeric protein is entirely a-helical and 
that the leucine zipper is oriented perpendicular to the axis of the DNA 
(Fig.1.20). Comparison of each leucine zipper coiled-coil reveals that they 
are essentially superimposable and virtually identical to the X-ray 
structure of the isolated GCN4 leucine zipper 40. Charged residues 
appearing at the e and g postions form only a small number of salt-
bridges, indicating that the stability of the dimer results mainly from 
interactions between residues at the core of the coiled-coil. 
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Fig.1.20. The GCN4-AP-1 DNA complex. 
Note: The X-ray structure coordinates upon which the above and 
following pictures are based were kindly provided by T. Ellenberger. 
Fig.1.21. The GCN4-AP-1 DNA complex viewed down the DNA. 
Fig.1.22. Amino acid-base contacts. 
37 
Fig.1.23. The arg-243-DNA interaction. 
Fig.1.24. Amino acid-base interactions viewed down the basic region. 
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The main differences between each complex concern the basic region and 
the DNA. In both complexes the basic region of each bZip monomer 
contacts a half-site of the DNA target sequence. The majority of contacts 
made between amino acid side-chains and DNA are conserved between 
each structure, however, a number of differences are apparent. 
In the GCN4-AP-1 complex the basic region contacts the DNA in the 
segment comprising residues 232 to 249 (Fig.1.22). Contacts to DNA 
bases are made by a number of residues. Asn-235, which is conserved 
throughout the bZip family, accepts a hydrogen bond from the N4 of C(-2) 
while donating a hydrogen bond to 04 of T(+3). Additional contact 
appears to be mediated through a water molecule which allows 
interaction with the N6 and N7 ofA(+4). -DNA base contacts are also 
made by ala-238 and ala-239 which are in van der Waals contact with the 
5-methyl groups of T(+3) and T(-1) respectively. Ser-242, which contacts 
the phosphate backbone, is also in hydrophobic contact with the 5-methyl 
group of T(+3). The asymmetry of the AP-1 site causes GCN4 to contact 
the central base pair in an asymmetric manner. Arg-243 of the left half-
site monomer donates hydrogen bonds to 06 and N7 of G(0) (Fig. 1.23). 
However, arg-243 of the right half-site monomer is unable to interact 
with G(0) and donates a hydrogen bond to the unesterified phosphate 
oxygens of C(0) and A(+1) instead. All other contacts positioning the basic 
region on the AP-1 DNA are made by basic and polar residues which 
donate hydrogen bonds to the phosphate oxygens of the DNA backbone. 
The interactions between the basic region of GCN4 and the ATF/CREB 
DNA are remarkably similar to those observed between GCN4 and the 
AP-1 site. Contacts between protein and DNA are observed in the region 
between lys-231 and lys-246. Hydrophobic interactions equivalent to 
those observed in the AP-1 complex are made between ala-238, ala-239 
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and ser-242 and the ATF/CREB DNA bases. An additional hydrophobic 
contact, not observed in the AP-1 complex, is also made between the C1' 
atom of thr-236 and the C2 and C3 atoms of the G(0) deoxyribose, moeity. 
The contact between asn-235 and T(+3) and C(-2) is equivalent to that 
seen in the AP-1 site. However, no water mediated contact is observed in 
the ATF/CREB complex. The interaction between arg-243 and the 
ATF/CREB DNA is markedly different to that observed in the AP-1 
complex. The symmetrical nature of the ATF/CREB site allows arg-243 of 
each monomer to hydrogen bond with the N7 atom of G(0) and to a 
backbone phosphate. The remaining contacts between the basic region 
and DNA are mediated via interaction between amino acid side-chains 
and phosphate oxygens of the DNA backbone. The pattern of interactions 
is essentially similar to those observed in the GCN4-AP-1 complex. 
The DNA conformations are different in each complex. The conformation 
of the DNA in the GCN4-AP-1 complex is straight, B-form DNA, and it is 
unaffected by the binding of the protein. This fact is reflected in the DNA-
binding constant, which is higher than that for binding to the ATF/CREB 
site72 . 
The conformation of ATF/CREB DNA is different to that of AP-1 DNA. In 
the GCN4-ATF/CREB complex the DNA is bent symmetrically by 200 
towards the leucine zipper axis. In the unbound state ATF/CREB DNA is 
bent by approximately 11 0 , indicating that GCN4 induces a slight 
curvature in the DNA75. This distortion shifts the phosphate groups 
between A(+6) and G(+2) towards the leucine zipper axis placing them at 
essentially the same distance as those of the AP-1 site. Base-specific 
interactions are further enhanced by a slight curvature in the basic 
region between ala-233 and ala-239. This allows the base-specific 
interactions of asn-235 and ala-239 to be maintained. 
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The recognition of a specific DNA target by a protein clearly requires that 
both the protein and the DNA exhibit a degree of flexibility. In this case, 
GCN4 appears to exert its influence in two ways; stabilising the straight 
conformation of the AP-1 site and inducing a bend in the ATF/CREB 
DNA. 
1.7.3 DNA-binding specificity. 
The region of GCN4 N-terminal to the leucine zipper displays enormous 
flexibility. This flexibility is reflected in the diversity of sequences 
recognised by the protein. GCN4 displays maximum binding affinity for 
the AP-1 site, however, the fully symmetric ATF/CREB site is also 
recognised, albeit with slightly lower affinity 72. This lower binding 
constant is probably a result of the distortion of the basic region and DNA 
required for sequence specific binding. Many other symmetrical 
sequences, which differ only slightly from those above are also recognised, 
but with much lower affinity 71 ' 92 ' 94 . 
230 	235 	240 	245 	250 	255 
AALKRARNTEAARRSRARKLQRMKQLEDKVEE 
Fig.1.25. The GCN4 basic region and linker segment. 
The binding specificity of the GCN4 bZip region has been explored in a 
number of ways including the generation of synthetic peptides, mutants 
and chimeric proteins. 
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1.7.4 Synthetic peptides. 
In the wild-type protein the leucine zipper positions the basic region for 
sequence specific binding. However, peptides have been synthesised 
which possess only two basic regions joined via a disulphide link 95. These 
proteins carry enough information to specifically bind to the AP-1 and 
ATF/CREB sites, although with a much reduced binding constant. The 
basic region of GCN4 can be further reduced without altering the 
sequence specific recognition properties of the basic region markedly 61 ' 96 . 
Dipeptides consisting of only 20 residues of the basic region have been 
shown to bind both the ATF/CREB and AP-1 sites. Deletion experiments 
have suggested that the region between 231 and 245 is critical for DNA 
recognition96. Indeed the X-ray structures of the GCN4-DNA complexes 
show that the majority of contacts between amino acid side-chains and 
DNA bases occur in this region 59 ' 60 . 
The region between residues 245 and 255, in which the basic region 
diverges from the leucine zipper, is particularly important in determining 
the half-site preferences of GCN4 59. Peptides in which this region has 
been replaced by a bis(terpyridyl) iron II complex have been shown to 
bind preferentially to different DNA sites 97 ' 98 . Complexes containing 
different linker molecules were shown to orientate the basic region in 
ways which altered its binding preferences. The results suggested that 
the amino acid composition of the linker segment was of critical 
importance for half-site recognition. This fact was reinforced by the 
observation that the linker domains are not conserved across bZip 
families, but conserved within them. 
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1.7.5 Single mutants. 
Mutations of residues in the linker segment also alter the half-site 
preferences of GCN4. AP-1 proteins have an uncharged residue at 
position 247, whereas proteins of the ATF/CREB family have a charged 
residue at this position. Mutation of leu-237 of GCN4 to lys-247 or arg-
247 results in proteins with comparable binding affinity to GCN4, 
whereas, proteins in which residues 247, 249 and 250 are replaced by 
those of CREB show a reduction in binding affinity for the AP-1 site such 
that the ATF/CREB site is preferred by a factor of tw0 89. These results 
indicate that the composition of the linker region, which affects the angle 
of bifurcation of the basic region, is of importance in the selection of 
binding site and that the half-site preference of a protein can be changed 
by the mutation of residues within this region. 
The basic region contacts DNA in the region spanning residues 231 and 
249. Base-specific contacts are generated by asn-235, thr-236, ala-238, 
ala-239, ser-242 and arg-243. All other contacts occur via interactions 
between amino acid side-chains and the phosphodiester backbone of the 
DNA59 ' 60 . 
The majority of mutational studies of the GCN4 basic region have 
examined the effects of mutating the residues contacting the DNA bases. 
These studies have involved single and double point mutations, the 
generation of chimeric proteins and substitution of multiple residues of 
the GCN4 basic region with those of other bZip proteins. 
Asn-235 is conserved throughout the entire bZip family. Mutation of this 
residue in GCN4 shows that very few substitutions are tolerated 99 . 
Experiments investigating the binding of mutants to the AP-1 site have 
shown that only one mutant, trp-235, binds with high affinity. Screening 
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with symmetrically mutated AP-1 sites revealed that the trp-235 mutant 
bound specifically to the symmetrically mutated TTGACTCAA sequence, 
which is recognised only weakly by GCN4 100 . 
Further experiments investigating the role of asn-235 revealed that a 
slightly larger number of mutants at this position could be generated 101 . 
However, the majority of these bound only weakly to the ATF/CREB site 
and symmetrically mutated sequences. A mutant protein containing 
tryptophan at position 235 was shown to bind with altered specificity to 
the sequence AGGACGTCCT. In contrast to the trp-235 mutant 
described above, which binds to a site changed at the 4 postion, this 
mutant recognised a binding site which was altered at the 3 position. The 
reasons for this apparent discrepancy are not clear. Identical contacts are 
made between asn-235 in the wild-type protein and both the AP-1 and 
ATF/CREB DNA sequences, therefore it would be reasonable to assume 
that similar contacts would be made between the mutant protein and its 
favoured DNA target 59 '60 . The different sequence preferences of the trp-
235 mutant may reflect changes in the half-site spacing of the ATF/CREB 
site and any DNA bending induced by the trp-235 mutant. These results 
demonstrate that the rules governing the binding specificities of mutant 
proteins are complex and cannot be easily predicted. 
Ala-238 and ala-239 are in hydrophobic contact with T(+3) and T(-1) 
respectively. Identical contacts between these residues and the DNA 
bases are observed in both the AP-1 and ATF/CREB protein-DNA 
complexes 59 '60 . Mutation of these residues has been carried out and the 
binding of the resulting mutants to both the AP-1 site and the ATF/CREB 
site investigated. 
Studies show that relatively few mutations are tolerated at the 238 
position. Substitution of serine or cysteine results in a protein which is 
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able to bind with high affinity to the AP-1 site 99. However, identical 
mutant proteins have been shown to behave differently when incubated 
with DNA containing the ATF/CREB site 102. The ser-238 protein binds 
with high affinity whereas the cys-238 protein binds only weakly. 
Mutants with extended aliphatic side-chains, such as leucine and valine, 
bind only weakly to both sites, indicating that mutants at this position 
interact with DNA bases hydrophobically and that the binding is 
constrained by the size of the binding pocket. 
Mutation of ala-239 shows that a wide variety of mutants, which bind to 
the AP-1 and ATF/CREB sites, are tolerated 103. These substitutions 
include basic and neutral amino acids such as glycine and valine. Studies 
have shown that insertion of serine at this position results in a protein 
which displays broadened specificity for ATF/CREB related sequences. 
Single substitutions also result in mutant proteins of changed specificity. 
An alanine to cysteine conversion results in a protein which binds to 
ATF/CREB sites changed at the 1 position, whereas substitution with 
aspargine favours a site altered at the 2 position. 
A large number of mutations can be tolerated at the 242 position 102 . 
Mutant proteins containing cysteine, phenylalanine, histidine, leucine, 
methionine, glutamine, threonine, valine and tryptophan all bind to the 
ATF/CREB site with high affinity. A number of these mutants also 
display broadened specificity for symmetrically mutated ATF/CREB sites. 
Modelling studies suggest that hydrophobic interactions play an 
important part in the binding of these mutants to their targets. 
Arg-243 is conserved throughout the bZip family. This fact is reflected in 
the small number of mutations allowed at this position. Only two weakly 
binding mutants, lys-243 and tyr-243, have been identified 101 . 
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1.7.6 Double mutants. 
Relatively few proteins containing double mutations in the basic region of 
GCN4 have been generated. The majority of studies have focussed on the 
amino acids involved in contacting the DNA bases. 
Mutation of ala-238 and ser-242 results in a library of mutants in which 
very few actually bind to DNA 102. Those that are able to bind show 
broadened specificity for a number of ATF/CREB related sequences. 
Similarly, mutation of ala-239 and ser-242 results in a large number of 
mutants which display broadened specificity. For example, a cys-239/trp- 
242 mutant, binds to four symmetrically mutated sites, whereas a ser-
239/trp-242 mutant binds to nine 102. 
Mutation of the conserved residues, asn-235 and arg-243, results in only 
a small number of weakly binding mutants 101 . However, a his-235/trp- 
243 mutant does show a degree of selectivity for an ATF/CREB site 
altered at the 2 position. 
In general, the binding of double mutants follows the pattern 
demonstrated by the singly mutated proteins. A wide variety of sequences 
are recognised, with mutant proteins displaying broadened and altered 
specificities. As with singly mutated proteins the pattern of interactions 
between protein and DNA may differ significantly from that observed in 
the wild-type complexes. These factors make it extremely difficult to 
predict the binding specificity of a given protein, making the basic region 
of GCN4 an attractive target for random mutagenesis. 
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1.7.7 Chimeric proteins. 
A different method of creating 'new' proteins involves the practise of 
generating chimeric proteins via recombinant DNA techniques. The area 
of the basic region responsible for specific recognition of a DNA target can 
often be identified in this way. Many researchers have employed this 
method of generating hybrid proteins to identify these recognition regions 
and create proteins which have changed specificities. 
Suckow et al showed that replacement of residues 228 to 241 in the basic 
region of GCN4 with those of CIEBP resulted in a protein which bound to 
the CIEBP binding site 104. Further analysis, via stepwise replacement of 
residues, revealed that the region between thr-236 and ala-239 contained - - 
enough information to distinguish between the ATF/CREB and C/EBP 
targets. Substitution with the corresponding residues of TAF-1 revealed 
that the specificity of the hybrid could be switched to that of TAF-1. 
a 
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Fig.1.26. The GCN4 basic region helical wheel. 
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Similar studies investigating the DNA-binding specificity of GCN4-
C/EBP chimeras were carried out by Johnson 105. The experiments 
showed that as the fusion point of the chimeras was moved through the 
basic region, a transition between CIEBP and GCN4 binding specificity 
could be observed. Further experiments suggested that C/EBP and GCN4 
use equivalent segments of the basic region to contact DNA. Substitution 
of thr-236 and ala-239 of GCN4 with the corresponding residues of C/EBP 
resulted in a protein with broadened specificity for the C/EBP site. In 
combination with ala-227, these mutations were shown to confer greater 
CIEBP-like character to the GCN4 hybrid, indicating that residues on the 
same face of the basic region ct-helices are important in DNA recognition 
(Fig.1.26). - 
1.7.8 Future work. 
As described above, various studies have addressed the effects of 
mutating residues in the GCN4 basic region. The majority of these 
studies have employed site-directed mutagenesis to randomly mutate 
specific residues and have assessed the binding characteristics of the 
resulting mutants by gel retardation assay. 
As yet, a study employing random mutagenesis across a large area of the 
basic region has not been attempted. Previous evidence has indicated 
that the rules governing the binding of a bZip protein to DNA are 
complex and that residues outwith the conserved region may play an 
important part in determining binding specificity. Randomly mutating a 
large section of the basic region would therefore address the role of these 
residues and go some way towards simplifying the rules for the specific 
binding of a bZip protein to DNA. 
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CHAPTER TWO 
Materials and Methods 
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2.1 Materials. 
Sigma 	ammonium persuiphate, ampicilhin, DTT, EDTA, HEPES, 
IPTG, maltose, SDS, tetracycline, Tris, and most other 
chemicals. 
Fluka 	acrylamide, bisacrylamide, guanidinium hydrochloride, 
sodium perchlorate, TEMED. 
Difco 	bacto-agar, bacto-tryptone, yeast extract. 
Gibco BRL restriction enzymes, agarose, LMP agarose, exonuclease III, 
ATP, caesium chloride. 
Pharmacia Sephadex G-50, T4 DNA ligase, T4 polynucleotide kinase, 
Kienow fragment, DNA polymerase I, DNase I, dNTP's, 
dCTPaS, T7 sequencing kit. 
Amersham [35S] methionine, [a- 35S] dATP, [a- 32P] dCTP, [y- 32P]ATP. 
Stratagene A2APII kit, Taq DNA polymerase. 
USB 	T7 exonuclease. 
2.2 Bacterial strains and plasmids. 
The following strains of E. coli were used: 
SOLR: 	e14(mcrA), (mcrCB-hsdSMR-mrr)171, sbcC, recB, recJ, 
umuC::Tn5(kanr), uurC, lac, gyrA96, relAl, thi-1, endAl, A'R, 
[F', proAB, lacIZLM15]. Su- (non-suppressing) 
XL1-Blue: endAl, hsdRl7, supE44, thi-1, recAl, gyrA96, relAl, lac, 
[F', proAB, lacIqZMVl 15, TnlO(tetR)] 
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JM109: 	recAl, endAl, gyrA96, thi, hsdRl7, supE44, relAl, ?.-, 
E(lac-proAB), [F', traD36, proAB, lacIZiM15] 
TG1: 	supE, hsdL5, thi, D(lac-proAB), 
[F', traD36, proAB, laclq, lacZEM15] 
pBluescript SK- was derived from XZAPII which was used to clone the 
bZip and GCN4 genes 106"07 . 
pTZ19R is derived from pUC19 and was used to clone the OP1 DNA 
fragment'08' 109, 110 
YCp88-GCN4 was obtained from Prof. K. Struhi and used to isolate the 
GCN4 and bZip genes 84 . 
2.3 Maintenance of bacterial strains. 
All strains were stored at -70 0C in 15% (v/v) glycerol. A single colony was 
grown overnight at 37 0C in 3ml LB supplemented with the appropriate 
antibiotics. To 850j.tl of this culture was added 150j.il glycerol and the 
culture stored at 700C. Strains which were used regularly were also 
maintained on agar plates. 
2.4 Gowth media and supplements. 
LB (Luria Bertani) medium. 
LB medium contained the following: 
lOg 	bacto-tryptone 	 zI,i 
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lOg 	NaCl 
5g 	yeast extract 
Water was added to a volume of 1 litre and the pH adjusted to 7.5 before 
autoclaving. 
Bacto-agar (15gl1) was added for plates. 
For the growth of XL1-Blue and SOLR cells, the medium was 
supplemented with magnesium sulphate to a final concentration of 10mM 
and maltose to a final concentration of 0.2%. The appropriate antibiotic 
was also added. 
2xYTbroth. 	 - 




lOg 	yeast extract 
Water was added to a volume of 1 litre before autoclaving. 
Top agar. 
Top agar was used for the growth of bacterial plaques containing XZAPII. 






Water was added to a volume of lOOmi before autoclaving. 
M9 Minimal media. 
Minimal media was used for the growth of TG1 cells. It contained the 
following: 
50m1 1OxM9 salts 
imi MgSO4 (1M) 
5m1 20% glucose 
50.tl CaCl2 (1M) 
200tl thiamine (2mg/mi) 
Water to a volume of 500mi was added before autoclaving. Bacto-agar 
(7.5g) was added for plates. 





Water to a volume of 500mi was added and the pH adjusted to 7.4 before 
autoclaving. 
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ampicillin 	50mg/mi, filter sterilised, stored at 4 0C for 14 days. 
tetracycline 	12.5mg/mi in ethanol, filter sterilised, stored at -20 0C. 
X-gal 	 250mg/mi in DMF, stored at -20 0C. 
2.5 Preparation of CaC12 competent cells. 
From an overnight culture, 500.ti of cells were suspended in 20m1 of 
medium supplemented with the appropriate antibiotic. The cells were 
incubated at 37 0C with shaking until the 0D 600 was between 0.37 and 
0.5. The suspension was transferred to a 50m1 Falcon tube and 
centrifuged at 40C for 10 minutes at 12000g. The supernatant was 
removed and the cells resuspended in lOml cold 100mM CaCl2.  After 
repeated inversion of the tube, the cells were stored on ice for 20 minutes. 
The cells were centrifuged as before and the supernatant removed. The 
cells were resuspended in imi cold 100mM CaCl 2. These CaCl2  competent 
cells could be stored for up to 5 days at 4 0C. 
2.6 Transformation of CaC12 competent cells with plasmid DNA. 
50.il of competent cells were placed in an Eppendorf tube. 1.d of plasmid 
DNA was added, before vortexing gently to mix the contents. The tube 
was placed in a water bath at 37 0C for 30 seconds, before immediately 
transferring the tube to ice for 1 hour. The tube was then placed in a 
water bath at 42 0C for 2 minutes. 80041 of medium supplemented with 
the appropriate antibiotic was then added and the tube incubated at 37 0C 
for 50 minutes. The cells were centrifuged for 10 minutes at 12000g. The 
supernatant was removed and the cells resuspended in lOOj.d of medium. 
The tube was vortexed briefly and 50j.tl of the cells plated on agar plates 
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supplemented with the relevant antibiotic. The plates were incubated 
overnight at 37 0C. 
2.7 Small scale preparation of plasmid DNA (mini-prep). 
A single colony from a plate containing the appropriate cells was 
suspended in 3m1 of medium supplemented with the appropriate 
antibiotic. The bacteria were grown overnight at 37 0C with shaking. imi 
aliquots of the culture were placed in Eppendorf tubes and centrifuged at 
12000g for 5 minutes. The supernatant was removed and each pellet 
resuspended in 350j.tl of STET (100mM NaCl; 10mM Tris.HC1, pH 8.0; 
1mM EDTA; 5% v/v Triton X-100). 25d of freshly prepared lysozyme 
(10mg/mi in 10mM Tris.HC1, pH 8.0) was added and the mixture briefly 
vortexed. The tube was placed in a heating block at 100 0C for exactly 40 
seconds, before centrifuging at 12000g for 10 minutes. The supernatant 
was removed and 40j.d of sodium acetate (3M, pH 5.5) added to the 
supernatant along with 420jxl isopropanol. The solution was mixed by 
vortexing and stored at room temperature for 20 minutes. The pellet of 
nucleic acid was recovered by centrifugation at 12000g for 30 minutes at 
40C. 
2.8 Purification of DNA using Prep-A-Gene matrix 112 . 
The pellet of DNA was resuspended in TE (10mM Tris.HC1, pH 8.0; 1mM 
EDTA) and centrifuged to remove any undissolved clumps of protein. 
Prep-A-Gene matrix was added to the solution. (Note: ipi of matrix was 
added for every 0.2g of DNA). Binding buffer (50mM Tris.HC1, pH 7.5; 
1mM EDTA; GM NaCl04) equal to 3 times the combined volume of matrix 
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and DNA solution was added. The mixture was incubated at room 
temperature for 10 minutes with gentle mixing. The solution was 
centrifuged for 30 seconds before discarding the supernatant. The pellet 
was resuspended in 30 pellet volumes of binding buffer and vortexed 
briefly. The tube was centrifuged as before and the rinse with binding 
buffer repeated twice more. The pellet was then washed in 30 pellet 
volumes of wash buffer (40mM Tris.HC1, pH 7.4; 4mM EDTA; 800mM 
NaCl; 50% v/v ethanol) before centrifuging for 30 seconds and removing 
the supernatant. This step was repeated twice more, taking care to 
remove the last traces of wash buffer after the final wash. The bound 
DNA was eluted from the pellet in 2 pellet volumes of elution buffer 
(10mM Tris.HC1, pH 8.0; 1mM EDTA) by incubating for 5 minutes at 
450C. The tube was spun for 1 minute and the supernatant containing 
the purified DNA removed. A second extraction with 1 pellet volume of 
elution buffer was then carried out to recover the remaining DNA. 
2.9 Phenol extraction of nucleic acid solutions. 
The crude pellet of nucleic acids was resuspended in TE (10mM Tris.HC1, 
pH 8.0; 1mM EDTA). An equal volume of 
phenol]chloroform/isoamylalcohol (25:24:1) saturated in Tris.HC1 (10mM, 
pH 8.0) was added and the mixture vortexed for approximately 1 minute. 
The phases were separated by centrifugation at 12000g for 2 minutes. 
The upper aqueous layer was collected, taking care not to disturb the 
white precipitate at the phase interface, and the process repeated until no 
white precipitate appeared. An equal volume of 
chioroform/isoamylalcohol (24:1) was added and the solutions mixed by 
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vortexing as above. The phases were separated by centrifugation as above 
and the upper aqueous layer containing the nucleic acids collected. 
2.10 Ethanol precipitation of nucleic acids. 
Nucleic acids were precipitated from aqueous solution by addition of 
sterile sodium acetate to a final concentration of 0.3M and 2 volumes of 
ethanol. After incubation on dry ice for 1 hour, the nucleic acid was 
pelleted by centrifugation for 30 minutes at 12000g and 4 0C. The 
supernatant was removed and the pellet washed with 70% ethanol. The 
supernatant was removed and the pellet dried under vacuum. The pellet 
was then resuspended in the - appropriate volume of sterile water and 
stored at -20 0C. 
2.11 Preparation of plasmid DNA from a large volume culture. 
Late in the evening 2 x 500m1 cultures of bacteria containing the relevant 
plasmid were started in media supplemented with the appropriate 
antibiotic. The cells were grown overnight at 37 0C with shaking. Early in 
the morning the cells were harvested by centrifugation at 6000rpm for 10 
minutes at 40C in a GSA rotor. The supernatant was removed and the 
pellet resuspended in lOOml cold TE (10mM Tris.HC1, pH 7.5; 1mM 
EDTA). The cells were centrifuged again at 6000rpm for 10 minutes at 
40C in a GSA rotor. The pellet was retained and resuspended in 3ml TS 
solution (30mM Tris.HC1, pH 8.0; 25% sucrose). lml of lysozyme 
(10mg/mi) was added and the suspension incubated for 5 minutes at 4 0C. 
imi of EDTA solution (500mM EDTA, pH 8.5) and 400j.tl of DNase free 
RNase (10mg/mi) were added and the solution incubated at 4 0C for a 
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further 5 minutes. 5m1 of Triton mix (lml 10% Triton X-100; 12.5m1 
500mM EDTA, pH 8.5; 5m1 1M Tris.HC1, pH 8.0) was added and the tube 
inverted several times before incubating at 4 0C for 10 minutes until lysis 
occurred. The solution was then centrifuged at 15000rpm for 30 minutes 
at 40C in a SS34 rotor. The supernatant was transferred to fresh tube 
and made up to lOmi with lysis mix (15m1 TS solution; 5m1 500mM 
EDTA, pH 8.5; 25m1 Triton mix; 7m1 water). 9g of Caesium chloride was 
then added and the tube shaken gently to dissolve the Caesium chloride. 
The tube was stored on ice and 900pJ of ethidium bromide (lOmg/ml) 
added. The solution was mixed gently and the solution transferred to a 
heat seal tube using a syringe and needle. Checking that the tubes were 
balanced, each solution was centrifuged at 38000rpm for 60 hours at 
180C in a Ti50 rotor. 
The DNA bands were visualised under UV light and the lower of the two 
bands containing the plasmid DNA removed using a syringe and needle. 
2.12 Agarose gel electrophoresis of DNA. 
DNA samples were routinely analysed by electrophoresis in 1% agarose 
gels. Gels were prepared by boiling 0.5g of agarose in 50m1 of 1xTBE 
buffer. The solution was allowed to cool to approximately 45 0C before 
adding 141 of ethidium bromide (lOmg/ml). The gel was poured into the 
casting tray. The comb was added and the gel allowed to set at room 
temperature. The comb was removed and the gel placed in the 
electrophoresis apparatus. 1xTBE was added so as to just cover the 
surface of the gel. The DNA solutions were carefully pipetted into each 
well and electrophoresed at a constant voltage of 60V for 2-3 hours. The 
samples were visualised under UV light. 
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Samples to be loaded in gels were mixed with the appropriate volume of 
Gx loading buffer 11(0.25% bromophenol blue; 0.25% xylene cyanol; 15% 
Ficoll (Type 400) in water). 
2.13 Isolation of DNA from LMP agarose gels. 
Low melting point (LMP) agarose gels of the appropriate concentration 
were prepared as above using 1xTAE as a buffer. 
After electrophoresis at 60V the DNA was visualised under UV. The band 
of interest was excised from the gel using a scalpel and placed in an 
Eppendorf tube. 
The DNA was purified from the gel slice in one of three ways, depending 
on the size of the DNA fragment. 
Prep-A-Gene purification (for DNA fragments above 200bp) 112  
The volume of the gel slice was estimated and 3 volumes of Prep-A-Gene 
binding buffer added (section 2.8). The sample was heated at 50 0C until 
all the agarose had dissolved. The appropriate volume of Prep-A-Gene 
matrix was then added and the solution vortexed briefly before 
incubating at room temperature for 10 minutes. The Prep-A-Gene DNA 
purification procedure was then followed as described previously. 
Purification by Phenol extraction. 
The gel slice containing the DNA was heated to 70 0C for 5 minutes to 
melt the agarose before adjusting the volume to 500.d with TE (10mM 
Tris.HC1, pH 8.0; 1mM EDTA). An equal volume of phenol buffered in 
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Tris.HC1 (10mM, pH 8.0) was added and the sample vortexed vigorously. 
The phases were separated by centrifugation at 12000g for 1 minute. The 
upper phase was removed and transferred to a clean tube. The DNA was 
purified further as described previously (section 2.9). 
(iii) Purification via elution 113 
The gel slice was placed in an Eppendorf tube and incubated in 500.11 
water for 15 minutes. The gel was transferred to a 500p.l  Eppendorf tube 
containing a siliconised glass wool plug and frozen at 70 0C. The tube was 
punctured at the bottom and transferred to a 1.6ml Eppendorf tube. The 
tubes were centrifuged, at 12000g for 10 minutes and the eluant 
containing the DNA recovered. The DNA was then precipitated in the 
usual way (section 2.10). 
2.14 Native PAGE of nucleic acids. 
For a 5% native gel the following were combined: 
47.5m1 	distilled water 
15m1 	5xTBE 
7.5ml 	50% acrylamide:bisacrylamide 
4001.d 	10% ammonium persulphate 
The solution was mixed and sonicated for 15 minutes. 30il TEMED was 
added and the gel poured between the siliconised glass plates within 
vertical electrophoresis apparatus. A comb was added and the gel allowed 
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to set for 1-2 hours. The DNA samples were loaded and electrophoresed at 
20-3OmA for the appropriate amount of time. 
2.15 Denaturing PAGE of nucleic acids. 
Denaturing PAGE was carried out as above (section 2.14) except urea 
was added to a final concentration of 40% (w/v) and the solution made up 
to the appropriate volume with distilled water. 
2.16 Dideoxy sequencing of DNA. 
Sequencing of double and single-stranded DNA was carried out according 
to the method of Sanger et al using the T7 Sequencing Kit 
(Pharmacia) 114 . 
Before carrying out the sequencing reactions a 12% denaturing 
polyacrylamide gel was poured, allowed to set and pre-electrophoresed for 
1 hour at 60W (section 2.15). 
2.16.1 Annealing of primer to single-stranded template. 
The sequencing primer was annealed to each DNA sample as follows in 
an Eppendorf tube: 
10tl 	template DNA (1-2g) 
21.d 	primer DNA (4mg/ml) 
2.t1 	annealing buffer (350mM NaCl; 100mM 
MgC12; 280mM Tris.HC1, pH 7.5) 
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Each tube was vortexed briefly and centrifuged before incubating at 60 0C 
for 10 minutes. Each reaction was then incubated for a further 10 
minutes at room temperature. 
2.16.2 Annealing of primer to double-stranded template. 
The concentration of the double-stranded template DNA was adjusted 
such that 8.tl contained 1.5-2g. 
To denature the double-stranded template, the following were added to 
an Eppendorf tube: 
8.tl 	template (1-2jtg) 
2j.tl 	2M NaOH 
The tube was vortexed briefly and the contents incubated at 37 0C for 30 
minutes. 
3.tl of sodium acetate (3M) was added and 7tl of distilled water. 60j.&l of 
ethanol was added and the mixture placed on dry ice for 15 minutes. The 
DNA was pelleted by centrifuging at 12000g for 30 minutes at 4 0C. The 
supernatant was removed and the pellet washed in cold 70% ethanol 
before drying under vacuum. The dried pellet was resuspended in lOj.tl of 
distilled water. 
To 10.t1 of the denatured pellet was added 2j.tl of annealing buffer 
(350mM NaCl; 100mM MgCl2; 280mM Tris.HC1, pH 7.5) and 2j.il of 
primer (lOj.tg). The reaction was incubated at 37 0C for 20 minutes. The 
tube was then placed at room temperature for 10 minutes before 
proceeding with the sequencing reactions (see below). 
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2.16.3 Sequencing reactions. 
The sequencing reactions were carried out as follows: 
Four wells of an Elisa plate were labelled 'A', 'C', 'G' and 'T' respectively. 
2.5tl of 'A' mix-short, 'C' mix-short, 'G' mix-short and 'T' mix-short were 
pipetted into the corresponding wells. 
(Note: each sequencing mix contained 15tM of the relevant ddNTP in 
addition to 150j.tM of each dNTP, 10mM MgCl2,  50mM NaCl and 40mM 
Tris.HC1, pH 7.5) 
'Enzyme Premix' was then prepared as follows in an Eppendorf tube, 
water 	 n 
Labelling mix-dATP 	 3n il 
T7 DNA Polymerase (1.5U/jtl) 2n l 
[a- 35S]dATP (10Ci4tl) 	n 
where n = number of templates. 
(Note: labelling mix-dATP contained 2p.M dCTP, 2p.M dGTP and 2xM 
dTTP) 
6l of 'Enzyme Premix' was then added to each of the annealed templates 
and primers. The solutions were mixed gently and incubated at room 
temperature for 5 minutes. Meanwhile, the four sequencing mixes were 
warmed at 370C. 
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After incubation was complete, 4.5.jl of each of the labelling reactions was 
transferred into each of the four pre-warmed sequencing mixes and 
incubated at 37 0C for 5 minutes. 
5pi of Stop Solution (20mM EDTA, pH 7.5; 0.05% (w/v) xylene cyanol FF; 
0.05% (wlv) bromophenol blue) was added to each well and the reactions 
heated at 800C for 2 minutes. 
1.5.il of each reaction was loaded onto the pre-electrophoresed gel and 
electrophoresed at 60W for approximately 3 hours. 
The gel was washed in 10% methanoll10% acetic acid for 30 minutes and 
the gel dried for 3 hours at 80 0C. The dry gel was autoradiographed for 
36 hours at room temperature before developing the film and determining 
the DNA sequence. 
2.17 Construction of pOPi. 
pTZ19R was supplied on LB/ampicillin(50p.g/ml) plates in TG1 cells. A 
bacterial colony was grown Sm! LB supplemented with ampicillin 
(50g/m1) overnight at 37 0C with shaking. The plasmid DNA was isolated 
as described previously (sections 2.7, 2.8) and prepared for cloning of the 
OP1 DNA fragment as follows: 
2.17.1 Digestion with Smal. 
The following were placed in an Eppendorf tube: 
10.d 	pTZ19R DNA (10tg) 
(ipi 	sterile water 
2pi 	10xReact4 buffer 
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2tl 	Smal (10U/.tl) 
The contents were mixed, briefly and incubated at 37 0C for 3 hours. The 
reaction was stopped by heating at 70 0C for 10 minutes. The DNA was 
purified with Prep-A-Gene matrix (section 2.8) and precipitated (section 
2.10). The pellet was resuspended in 25jil sterile water. 
2.17.2 Digestion with EcoRI. 
The following were combined in an Eppendorf tube: 
20j.tl 	pTZ19R/SmaI DNA (10tg) 
2.5il 	10xReact 3 buffer 
2p.1 	EcoRI (10U/1t1) 
0.5p.l 	sterile water 
The contents were vortexed briefly and incubated at 37 0C for 3 hours. 
The reaction was stopped by incubating at 70 0C for 10 minutes. The DNA 
was purified using Prep-A-Gene (section 2.8) and precipited (section 2.10). 
The pellet was resuspended in 20tl sterile water and a 5.d sample 
removed for gel analysis. 
2.17.3 Ligation of OP1 DNA into pTZ19R. 
The following were combined in an Eppendorf tube: 
2.t1 	pTZ19R/SmaI/EcoRI (50ng) 
0.5d 	OP1 DNA (lOng) 
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0.5il 	T4 DNA ligase (1U4d) 
0.5pi 	10mM ATP 
0.5p.l 	lOx ligation buffer 
1tl 	sterile water 
The contents were mixed briefly and incubated at 4 0C overnight. The 
recombinant plasmid DNA was transformed into fresh competent TG1 
cells (sections 2.5, 2.6) and grown on LB/ampicillin(50p.g/ml) plates. 
The clones were identified by dideoxy sequencing (section 2.16) and 
stored as a glycerol stock (section 2.3). 
2.18 Labelling of OP1 DNA with [a- 32P]dCTP. 
2.18.1 Preparation of OP1 DNA fragment. 
A large scale culture of pOPi DNA was prepared (section 2.11) and used 
to prepare the OP1fragment. 
2.18.2 Digestion with EcoRI. 
The following were combined in an Eppendorf tube: 
25.t1 	pTZ19R DNA (lOj.tg) 
3.d 	10xReact3 buffer 
2j.tl 	EcoRI (10U/ml) 
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The contents were mixed briefly and incubated at 37 0C for 3 hours. The 
reaction was stopped at 70 0C for 10 minutes. The DNA was precipitated 
(section 2.10) and resuspended in 25p.l of sterile water. 
2.18.3 Digestion of XbaI. 
The following were combined in an Eppendorf tube: 
25p1 	pTZ19R/EcoRI DNA (10g) 
3l 	10xReact2 buffer 
2.tl 	XbaI (10U/.il) 
The contents were mixed briefly and incubated at 37 0C for 3 hours. The 
reaction was stopped by heating at 70 0C for 10 minutes. 
The DNA was purified via LMP agarose gel electrophoresis (section 2.13). 
2.18.4 Radioactive labelling of OP1 DNA with [a- 32P]dCTP. 
The following were combined in an Eppendorf tube: 
20j.tl OP1 DNA (ip.g) 
5p.l sterile water 
3,JJ 10xReact3 buffer 
1.tl [a 32P]dCTP (lOmCi/ml) 
Kienow fragment (10U/pJ) 
The contents were mixed briefly and incubated at 37 0C for 30 minutes. 
The reaction was stopped by heating at 70 0C for 10 minutes. 
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The DNA was purified via two rounds of ethanol precipitation (section 
2.10) and resuspended in 10.d sterile water and stored at 200C  in a 
perspex container. 
(Note: All manipulations involving 32P  were carried out behind a perspex 
shield.) 
2.19 PCR of the GCN4 bZip region from YCp88-GCN4. 
Before carrying out the PCR, the plasmid DNA was linearised via 
digestion with BamHI. The restriction digest was analysed by agarose gel 
electrophoresis and the linearised DNA purified using Prep-A-Gene 
matrix (setion 2.8). 
The following were then placed in a 50041 Eppendorf tube: 
0.5p.l primer 575P (0.07MM) 
0.5j.tl primer 576P (0.07MM) 
0.5jtl Taq Polymerase (5U/p.l) 
2p1 dNTP's (5mM) 
5.tl 1OxPCR buffer 
lO.tl YCp88-GCN4 DNA (lp.g) 
31.5tl sterile distilled water 
The solutions were overlayed with 40jtl mineral oil and centrifuged 
briefly. The tube was placed in a Techne PHC-3 Thermal Cycler. The 
following cycle was then implemented, 
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900C 2 mins 
90°C 1 mm 
540C 1 min 	30 cycles 
720C 2 mins 
720C 5 mins 
The product of the PCR was checked by electrophoresis at GOV on a 2% 
agarose gel. 
5.tl portions of the crude PCR products were digested with lOU EcoRI in 
React3 buffer. The reactions were incubated for 2 hours at 37 0C. The 
enzyme was deactivated by heating at 70 0C for 10 minutes. 
The bZip DNA was separated from the other fragments via LMP agarose 
gel electrophoresis (section 2.13). The DNA was purified using Prep-A-
Gene matrix (section 2.8). 
2.20 PCR of the GCN4 gene from YCp88-GCN4. 
The PCR of the GCN4 gene was carried out in an identical manner to 
that above, except primer 575P was replaced by primer 120X at an 
identical concentration. 
2.21 Construction of XZAPII library. 
The ligation and packaging reactions were carried out using a kit 
purchased from Stratagene. 
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2.2 1.1 Ligation of bZip gene into ?.ZAPII arms. 
The following were placed in an Eppendorf tube: 
2l bZip DNA (5ng) 
?2APII/EcoRI arms (lpg) 
0.5j.tl lOx ligation buffer 
0.5.d 10mM ATP 
0.5j.tl T4 DNA ligase (4U/.tl) 
0.5tl sterile water 
The reaction was incubated overnight at 4 0C. 
2.2 1.2 Ligation of GCN4 gene into ?2APII arms. 
The ligation of the GCN4 gene into ?ZAPII was carried out in an identical 
manner to that for the bZip region except the bZip DNA was replaced by 
2.t1 GCN4/EcoRI DNA (20ng). 
2.2 1.3 Packaging of XZAPII DNA. 
This was carried out as follows using Gigapack II Plus packaging extract 
purchased from Stratagene: 
Two extracts (1 yellow, 1 red) were removed from a -70 0C freezer and 
placed on dry ice. At the same time Sonic extract (yellow tube) was 
thawed. The Freeze/Thaw extract (red tube) was quickly thawed between 
fingers until it just began to thaw. 3jtl of the ligated XZAPII DNA was 
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added immediately to the Freeze/Thaw extract before placing on ice. 15p.l 
of Sonic extract was added before stirring carefully to avoid air bubbles. 
The tube was centrifuged briefly. The mixture was then incubated at 
room temperature for 2 hours. 500j.tl of SM was added, before adding 20.d 
of chloroform. The tube was mixed gently before centrifuging briefly to 
sediment the debris. The supernatant was removed and stored at 40C. 
2.21.4 Preparation of host bacteria. 
20m1 of LB supplemented with maltose (0.2% w/v) and MgSO 4 (10mM) 
was inoculated with a single colony of XL1-Blue bacteria. The broth was 
grown for approximately 8 hours at 37 0C with shaking until the 0D600 
reached 1.0. The bacteria were then pelleted at 12000g for 10 minutes 
before resuspending the cells in lOml of MgSO 4 (10mM). These cells were 
stored at 40C for up to 2 days. 
2.21.5 Infection of packaged ?ZAPII phage into E.coli. 
The packaged ?ZAPII phage were diluted by a factor of 102  and 104  in SM 
(100mM NaCl; 10mM MgSO4; 50mM Tris.HC1, pH 7.5; 0.01% w/v 
gelatin). lOj.tl of each sample was added to 200d XL 1-Blue cells before 
incubating at 370C for 20 minutes. 3m1 of top agar at a temperature less 
than 500C was added to each and the mixture quickly poured onto 
LB/tetracycline (12.5p.g/ml) plates. The plates were incubated overnight 
at 370C and the phage titre recorded. 
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2.21.6 Amplification of ?.ZAPII phage. 
XL1-Blue cells were grown to an 0D 600 0.5 and 100il mixed with ?ZAPII 
phage (1x10 6 pfu). The suspension was incubated for 15 minutes at 37 0C 
and added to 4m1 LB supplemented with MgSO 4 (10mM) and maltose 
(0.2% w/v). The cells were grown overnight at 37 0C with shaking. 
Chloroform (2 drops) was added and the incubation continued for a 
further 15 minutes at 37 0C. The cells were pelleted at 12000g for 20 
minutes and the supernatant retained. Chloroform (1 drop) was added 
and the suspension stored at 4 0C. 
2.21.7 Blue/white colour test for recombinant phage. 
10.tl of ?.ZAPII phage were added to 200.tl XL1-Blue cells (0D 600=0.5 in 
10mM MgSO4) and incubated for 20 minutes at 37 0C. 3m1 of top agar, 
iSp! of IPTG (500mM) and 50p.l of X-gal (250mg/mi) were added and 
plated on LB/tetracycline (12.5p.g/ml) plates. The plates were incubated 
overnight at 37 0C. 
2.22 In vitro screening of ?ZAPII library. 
XL1-Blue host bacteria were prepared as previuosly described. 5j.tl 
batches of a 1x10 2 dilution of XZAPII-bZip phage in SM (100mM NaCi; 
10mM MgSO4; 50mM Tris.HC1, pH 7.5; 0.01% w/v gelatin) were added to 
200j.tl of XL1-Blue cells and the broth incubated at 37 0C for 20 minutes. 
3ml of top agar was added and the mixture poured onto LB/tetracycline 
(12.5p.g/mi) plates. The plates were incubated at 37 0C for 4 hours until 
the plaques were barely visible. A nitrocellulose filter was soaked in 
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IPTG (10mM) and dried at room temperature before laying it over a 
plate. The plates were incubated for a further 4 hours at 37 0C then 
chilled at 40C for 30 minutes. The filter was marked by pushing a needle 
filled with ink through both filter and plate. The filter was peeled off and 
allowed to dry before being subjected to the following cycle of washing, 
denaturing, renaturing and probing: 
2 x 5 mins GM Gu.HC1 in lx buffer 
2 x 5 mins 3M Gu.HC1 in lx buffer 
2 x 5 mins 1.5M Gu.HC1 in lx buffer 
2 x 5 mins 0.75M Gu.HC1 in lx buffer 
5 mins lx buffer 
5 mins lx buffer +5% NFDM 
5 mins lx buffer + 0.25% NFDM 
overnight lx buffer, 0.25 NFDM, 
sonicated salmon sperm DNA(lOmg/ml), 
3.tl of 32P-labelled probe DNA. 
3 x 5 mins lx buffer + 0.25% NFDM 
The nitrocellulose filters were allowed to dry at room temperature before 
laying on filter paper and establishing an autoradiograph. 
Positive plaques were isolated by coring with a sterile pipette end. Each 
plaque was placed in an Eppendorf tube and dissolved in 500.tl SM 
(100mM NaCl; 10mM MgSO4; 50mM Tris.HC1, pH 7.5; 0.01% w/v gelatin) 
and 20j.tl chloroform. Each tube was vortexed to release the phage 
particles into the SM (100mM NaCl; 10mM MgSO 4; 50mM Tris.HC1, pH 
7.5; 0.01% w/v gelatin). The samples were incubated at room temperature 
for 2 hours. Serial dilutions were made and stored at 40C. 
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(Note: lx buffer contained the following 25mM HEPES, pH 7.5; 10mM 
DTT; 4mM KC1; 3mM MgC1 2) 
223 In vivo excision of pBluescript SK- phagemids. 
The following were combined in an Eppendorf tube: 
200.tl 	XL1-Blue cells (0D 600=0.5 in 10mM MgSO4) 
200.tl 	XZAPII phage stock (1.5x10 4 pfu/ml) 
lp.l 	Exassist helper phage (>lxlO'° pfulml) 
3m1 of 2xYT medium was added and each sample incubated at 37 0C for 3 
hours with shaking. The cells were then heated at 70 0C for 20 minutes 
before centrifuging for 20 minutes at 12000g. The supernatant containing 
the pBluescript SK- phagemid was removed and stored at 4 0C. 
10d of phage stock was added to 200.tl SOLR cells (0D 600=0.5 in 10mM 
MgSO4) in a sterile Eppendorf tube and incubated at 37 0C for 15 
minutes. 100tl of the suspension was plated on LB/ampicillin 
(50p.g/ml)Ikanamycin (50tg/ml) plates and incubated overnight at 37 0C. 
2.24 Preparation of pBluescript SK- single-stranded DNA. 
Early in the morning, cultures of SOLR bacteria, containing the relevant 
pBluescript SK- phagemid, were started from single colonies taken from 
LB/ampicillin (50p.g/ml) plates. The cultures were grown in LB medium 
supplemented with maltose (0.2% w/v), MgSO 4 (10mM), ampicillin 
(50pg/ml) and kanamycin (50j.tg/ml). Late in the afternoon 3m1 batches of 
LB, supplemented as above, were inoculated with enough bacteria to 
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obtain an 0D 600=0.05. The cultures were grown to an 0D 600=0.1 before 
adding R408 helper phage (>7.5x10'° pfu/ml) to each culture at a 
multiplicity of infection (moi) of 1:1. The cells were grown overnight at 
370C with shaking. 
In the morning the cells were heated for 15 minutes at 65 0C before 
centrifuging at 12000g for 2 minutes to precipitate the cell debris. 1.2m1 
aliquots of the supernatants were then transferred to fresh tubes and the 
single stranded phage precipitated by addition of 300j.il ammonium 
acetate (3.5M, pH 7.5); 20% PEG solution. The tubes were inverted to mix 
before incubating at room temperature for 30 minutes. The phage were 
pelleted by centrifugation at 12000g for 20 minutes. The supernatants 
were removed and the tubes spun for a further minute and any remaining 
supernatant removed. The pellets were resuspended in 200d TE (10mM 
Tris.HCL, pH 8.0; 1mM EDTA) and stored at -20 0C. 
The single-stranded DNA was purified either via extraction with phenol 
(section 2.9) or adsorption onto Prep-A-Gene matrix (section 2.8). 
2.25 Helper phage amplification. 
lOmi XL1-Blue cells were grown in LB supplemented with maltose (0.2% 
w/v) and MgSO 4 (10mM) to an 0D 600 0.3 at 370C with shaking. Helper 
phage at a multiplicity of infection of 20:1 was added and the cells grown 
for a further 8 hours at 37 0C with shaking. The cells were heated at 65 0C 
for 15 minutes and centrifuged at 12000g for 5 minutes. The supernatant 
was retained and stored at 40C 
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2.26 [35S]MethioninellPTG  induction of fusion protein. 
A bacterial colony of SOLR cells containing the relevant pBluescript SK-
phagemid was grown in lOmi LB supplemented with maltose (0.2% w/v), 
MgSO4 (10mM) and ampiciffin (50g/ml) at 37 0C with shaking to an 
0D600=0.4. IPTG to a final concentration of 10mM was. added, along with 
5tl of [35S]Methionine (lOmCiIml). The culture was then incubated at 
370C with shaking. imi aliquots were removed at '/2, 1, 2 and 3 hours. 
Each aliquot was centrifuged for 2 minutes at 12000g and the pellet 
resuspended in SDS loading buffer. 
A 10-20% gradient SDS-polyacrylamide gel was poured and overlayed 
with a 3% stacking gel (section 2.30). The gel was allowed to set before 
loading each of the protein samples. The gel was electrophoresed at 30mA 
for 7 hours. The gel was stained in Coomassie Blue R250 then destained 
for 24 hours in 40% methanoll10% acetic acid/50% water at room 
temperature. The gel was dried at 80 0C for 3 hours and overlayed with 
XOMAT film. The radioactive gel was autoradiographed for 36 hours, 
before developing the film to observe the image. 
2.27 Large scale preparation of fusion protein. 
A 20m1 culture of SOLR cells containing the relevant pBluescript SK-
phagemid was grown in LB supplemented with maltose (0.2% w/v), 
magnesium sulphate (10mM) and ampicilhin (50pg/m1) overnight at 37 0C 
with shaking. The culture was transferred to 500ml LB, supplemented as 
above, and grown for 2 hours at 37 0C with shaking, to an approximate 
0D600 of 1.0. 50m1 batches of this culture were transferred to flasks 
containing 500m1 of LB, supplemented as above, and grown for 
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approximately 2 hours to an 0D 600 of 0.4. IPTG to a final concentration of 
1mM was added to each flask and the cultures grown for a further 3 
hours at 370C with shaking until the 0D 600 was approximately 1.0. 
The cells were then centrifuged at 5000rpm for 10 minutes at 4 0C in a 
GSA rotor. The pellets were recovered and resuspended in lOml HEPES 
(50mM, pH 7.5). Each sample was placed on ice and sonicated 15 times 
for 30 seconds at 30 second intervals. The suspension was then 
centrifuged at 14000rpm for 15 minutes at 4 0C in a SS34 rotor. The 
supernatant was removed and 200.tl DNase I (1mg/mi) added to each. 
Each sample was incubated at room temperature for 30 minutes. The 
samples were centrifuged at 14000rpm for 15 minutes at 4 0C in a SS34 
rotor and the supernatant transferred to a fresh tube. 
2.28 Ammonium sulphate fractionation of cell free extract. 
The cell free extract was fractionated by addition of ammonium sulphate 
to final concentration of 40% at 4 0C with constant stirring. The sample 
was centrifuged at 15000rpm for 10 minutes at 4 0C in a SS34 rotor and 
the supernatant retained. Ammonium sulphate was added to final 
concentration of 60% at 4 0C with stirring. The sample was then 
centrifuged at 15000rpm for 10 minutes at 4 0C as before and the pellet of 
protein resuspended in the minimum volume of HEPES (50mM, pH 7.5) 
and dialysed for 1-2 days at 4 0C. Samples were stored as a 15% glycerol 
stock at -200C. 
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2.29 Gel filtration chromatography. 
A slurry of Sephadex G-50 resin in HEPES (50mM, pH 7.5) was prepared 
and poured into a glass column The resin was allowed to settle and then 
washed with 500m1 buffer at imllmin. The column was loaded with 500.d 
cell free extract and eluted with HEPES (50mM, pH 7.5) at imllmin. The 
eluant was monitored at 280nm and the fractions collected at 15 minute 
intervals until no further proteins eluted from the gel. The protein 
fractions were identified and concentrated by ultraffitration through a 
YM-3 membrane at 4 0C. The concentrated samples were identified via 
SDS-PAGE and the concentration determined. 
2.30 SDS-Polyacrylamide gradient electrophoresis. 
Two different percentage (10% and 20%) polyacrylamide solutions were 
made as follows: 
10% 
lOml 	water 
8.3m1 	30% acrylamide:bisacrylamide 
6.3ml 	Tris.HC1 (1.5M, pH 8.8) 
250.d 	10% SDS 
100 j.tl 	10% ammonium persulphate 
20% 
1.75ml water 
16. 6m1 30%acrylamide :bisacrylamide 
6.3ml 	Tris.HC1(1.5M, pH 8.8) 
250pi 10% SDS 
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100!d 	10% ammonium persuiphate 
Each solution was sonicated for 15 mitutes before adding 7.5m1 TEMED 
to each. The solutions were immediately poured into separate chambers 
of a gradient former which was connected to a peristaltic pump. The 
polyacrylamide solution was pumped between two glass plates and 
overlayed by water. 
A 3% stacking gel was made as follows and poured onto the gradient gel 
after it had set: 
3% 
6.1ml 	water 
2.5ml 	Tris.HC1 (0.5M, pH 6.8) 
1.3m1 	30% acrylamide:bisacrylamide 
lOOil 	10% SDS 
50.t1 	10% ammonium persuiphate 
101 	TEMED 
A comb was inserted into the top of the gel, between the glass plates, 
which was then left to polymerise. 
The gradient gel was attatched to a vertical gel electrophoresis apparatus 
(Biorad Protean II Slab Gel) and running buffer (180mM Glycine; 25mM 
Tris; 0.1%(w/v) SDS) added. 
The protein samples were suspended in an equal volume of sample buffer 
(100mM Tris.HC1, pH 6.8; 20% (v/v) glycerol; 15% -mercaproethanol; 3% 
(wlv) SDS; 0.25% (w/v) bromophenol blue) and boiled for 5 minutes. The 
samples along with protein standards were loaded onto the gel and 
electrophoresed at 20mA for 4 hours. 
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The gel was removed from the apparatus and stained with Coomassie 
Blue R250 in 40% methanoll10% acetic acid for 30 minutes. The gel was 
destained in 40% methanoll10% acetic acid and the sample visualised. 
The gel was then dried under vacuum at 80 0C for 1 hour. 
2.31 Determination of protein concentration. 
The procedure was carried out according to that previously described by 
Bradford" 5 
50mg of Coomassie Blue G-250 was dissolved in 25m1 of 95% ethanol. 
This was added to 48.5m1 of 88% phosphoric acid and the solution made 
up to 500m1 with distilled water. 
BSA to a concentration of lmg/ml was suspended in HEPES (50mM, pH 
7.5) and a series of dilutions made. 5m1 of the reagent solution was added 
to 100.d of each protein solution and the absorbance at 595nm measured. 
A graph of protein concentration versus absorbance was plotted and used 
to determine the amount of protein from an unknown 100.d sample. 
2.32 Gel retardation assay. 
A series of dilutions of the purified protein were made and stored at 4 0C. 
OP1 DNA was labelled with [a- 32P]dCTP to a high specific activity 
(section 2.18) and a 5% native polyacrylamide gel poured (section 2.14).. 
The following were then combined in an Eppendorf tube: 
32P-labelled OP1 DNA 
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10.d 	2x retard buffer (50mM HEPES, pH 7.5; 
80mM NaCl; 10mM MgC12; 0.2mM EDTA; 
1mM DTT; 8% Ficoll) 
1j.11 	sonicated salmon sperm DNA (1mg/mi) 
1-8tl 	protein in HEPES (50mM, pH 7.5) 
Each sample was made up to 20j.d with sterile water, mixed and 
incubated on ice for 1 hour. 
Each sample was loaded onto a pre-electrophoresed gel at 4 0C and 
electrophoresed at 30mA until the samples had entered the gel, then at 
20mA for 2 hours. 
The gel was placed in a cassette and overlayed with XOMAT film for 2-3 
hours at 700C.  The film was developed and the retarded bands 
identified. 
(Note: all manipulations involving 32p  were carried out behind a perspex 
shield.) 
2.33 In vitro mutagenesis. 
2.33.1 Phosphorylation of spiked oligonucleotide. 
The following were combined in an Eppendorf tube: 
14tl sterile water 
6.tl 500mM Tris.HC1, 1mM EDTA (pH 8.0) 
2.d spiked primer (5 0D260/ml) 
3.iJ 100mMATP 
3d 100mM MgCl2 
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2tl 	100mMDTT 
1tl 	T4 polynucleotide kinase (10U/p.!) 
The contents of the tube were vortexed briefly before incubating at 37 0C 
for 30 minutes. The reaction was stopped by incubating at 70 0C for 10 
mimutes. 
2.33.2 Labelling of spiked primer with [y-32P]ATP. 
The spiked oligonucleotide was labelled under identical conditions to 
those used above (section 2.33.1) except the ATP was replaced by 1p.l [y -
32P]ATP (lOmCiJml) and 2p.l of sterile water. 
The DNA was loaded onto a denaturing polyacrylamide gel and 
electrophoresed (section 2.15). The gel was placed in a cassette and 
exposed to XOMAT film for 2-3 hours at -700C. The film was developed 
and the bands visualised. 
2.3 3.3 Preparation of RF-IV DNA. 
Annealing of spiked primer to template DNA. 
The following mixture was combined in a sterile Eppendorf tube: 
10p.1 	500mM Tris.HC1, 1mM EDTA (pH 8.0) 
10p.l 	500mM NaCl 
lOp.d 	single-stranded pbZip DNA (1p.g/p.l) 
6p.l 	phosphorylated spiked primer 
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The mixture was incubated at 70 0C for 5 minutes, 55 0C for 20 minutes 
and 370C for 30 minutes in a thermal cycler. The solution was then 
placed on ice. 
Polymerisation. 
The following were added to the template/primer mixture after the 
annealing mixture had been cooled on ice: 
2.591 10mM dATP 
2.591 10mM dGTP 
2.5j.tl 10mM dTTP 
2.591 10mM dCTPaS 
lOjd 10mM ATP 
10.tl 100mM MgC12 
3.tl 500mM Tris.HC1, 1mM EDTA (pH 8.0) 
1J.Ll Kienow fragment (10U/p.1) 
2j.d T4 DNA ligase (7U/tl) 
8i.l sterile water 
The contents were mixed and spun briefly before incubating for 40 hours 
at 160C. The reaction was stopped by heating at 70 0C for 10 minutes. 
A 10tl sample was removed for gel analysis. 
2.33.4 Strand specific nicking of RF-IV DNA. 
The polymerised RF-IV DNA was precipitated by addition of sodium 
acetate to a final concentration of 0.3M and 2 volumes of ethanol for 1 
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hour on dry ice. The DNA was pelleted at 12000g for 30 minutes at 4 0C. 
The pellet was then washed in 70% ethanol and dried under vacuum. 
The following were added to the pellet: 
sterile water 
5p.l 100mM DTT 
3m1 100mM MgC12 
3m! 500mM NaCl 
1.2m1 500mM Tris.HC1, 1mM EDTA (pH 8.0) 
3tl Neil (7.504tl) 
The reaction was incubated at 37 0C for 3 hours. The enzyme was 
inactivated by heating at 70 0C for 10 minutes. 5d was removed for gel 
analysis. 
2.33.5 Exonuc!ease III gapping reaction. 
0.8.tl NaCl (5M) was added to the nicked DNA solution (section 2.33.4) 
and the solution cooled on ice. 31.d exonuclease III (65U/j.d) was added and 
the reaction vortexed briefly. The reaction was incubated at 37 0C for 30 
minutes before heating at 70 0C for 10 minutes. 
A 10p.1 sample was removed for agarose gel electrophoresis. 
2.33.6 T7 exonuclease gapping reaction. 
The nicked DNA (section 2.33.4) was precipitated (section 2.10) and 
resuspended in the following: 
84 
24.tl 	sterile water 
3p.l 	10xReact8 buffer 
T7 exonuclease (50U4tl) 
The reactants were mixed briefly and incubated at 37 0C for 50 minutes. 




The ?ZAPII system 
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3.1 Overview. 
The central aim of this project was to clone the bZip region of GCN4 into 
a vector which allowed expression of the protein, identification of clones 
and mutagenesis without the need for subcloning. 
A vector system which was ideal for the experiments described herein 
was the ?ZAPII system 106"16. This vector allows the cloned gene to be 
screened with radioactive DNA probes in vitro via induction of the cloned 
gene with IPTG and subsequent transfer of the fusion protein to 
nitrocellulose. Identification of DNA-binding proteins is facilitated by 
excising the pBluescript SK- phagemid, contained within the ?2APII 
genome, and sequencing the phagemid-derived single-stranded DNA 
produced. 
Excision of the pBluescript SK- phagemid allows overexpression of the 
bZip fusion protein with IPTG. The binding characteristics of the fusion 
protein can then be investigated further via gel retardation assay. 
Single-stranded phagemid DNA can then generated and used to carry out 
in vitro mutagenesis of the bZip gene. The mutant library can be recloned 
into XZAPII and any mutants which bind to target DNA characterised 
following the procedures described above. 











gel retardation assay 




Fig.3.1. The ?ZAPII system. 
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3.2 Preparation of the GCN4 and bZip genes via PCR. 
3.2.1 Introduction. 
The first stage of the project was to isolate the genes of interest and 
manipulate them such that they could be cloned into a suitable vector, 
which in this case was XZApII106,116.  A convenient way of doing this was 
to amplify the appropriate DNA sequences via polymerase chain reaction 
(PCR) from the plasmid YCp88-GCN4 which contains the entire GCN4 
gene84 ' 117. 
PCR is a simple process, which involves the use of synthetic 
oligonucleotides and a DNA polymerase enzyme to carry out the semi-
synthetic amplification of the target DNA sequence. Briefly, short 
synthetic oligonucleotide primers designed to bind different strands of a 
larger, double-stranded target sequence are synthesised. The target DNA 
is mixed with a large excess of the primers, and the temperature raised to 
thermally denature the double-stranded target. The temperature is 
lowered, and the primers anneal to their respective sites on the target. A 
thermostable DNA polymerase enzyme and deoxynucleotide 
triphosphates (dNTP's) are present in the reaction mixture and DNA 
synthesis then proceeds from the 3'-ends of the primers, copying the 
target strand to which the primer is bound, until the end of the target is 
reached. This constitutes one cycle. The entire process can be repeated a 
number of times thereby exponentially amplifying the DNA target 
sequence. 
PCR has a number of advantages over other methods of isolating DNA 
sequences from plasmids. 
(i) Small quantities of DNA can be amplified easily. 
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The DNA can be manipulated such that restriction sites and 
other sequences not present in the wild-type sequence can be engineered 
into the final product. 
The DNA sequences can be deleted to a suitable size simply by 
altering the primer sequence. 
The amplified DNA can be purified easily. 
3.2.2 The GCN4 gene. 
The GCN4 gene is 281 residues in length and the region of interest, the 
bZip region, is situated at the amino-terminus between residues 226 and 
281. This region is able to bind DNA independently from the rest of the 
protein84 (Fig. 3.2). 
activation 	 DNA-binding 
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Fig.3.2. Schematic representation of the GCN4 protein. 
It was decided to isolate and clone both the full length GCN4 gene and 
the GCN4 bZip region. Cloning the full length GCN4 gene into ?.ZAPII 
would ensure that the 3-galactosidase sequences would be separated from 
the DNA-binding region and would therefore be unlikely to interfere with 
the binding of the fusion protein to DNA. 
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3.2.3 Design of PCR primers. 
A number of different criteria were considered when designing the 
oligonucleotide primers for each DNA sequence. 
The bZip gene. 
The bZip region is situated between residues 226 and 281 of the GCN4 
gene. The PCR process requires two primers; one which anneals to the 
start of the gene (the start primer) and one which anneals to the end of 
the gene (the stop primer). Because the two DNA strands of the plasmid 
are denatured during the PCR process, a primer which is complementary 
to the start of the non-coding strand and a primer which is 
complementary to the end of the coding strand are required. Therefore, 
sequences which were complementary to these segments of the bZip 
region were included in each of the primers. 
The sequence of each primer was also constrained by the nature of the 
cloning vector. Since the amplified bZip DNA was eventually cloned into 
an EcoRI site within the multiple cloning site of AZAPII, it was necessary 
to engineer an EcoRI sequence in each primer. It was also essential to 
ensure that the bZip DNA could be inserted into the lacZ gene of XZAPII 
within the correct reading frame for gene expression. This was achieved 
by analysing the sequences of the lacZ gene of XZAPII and those of the 
plasmid derived sequence and tailoring the sequence of each of the 
primers to allow in frame insertion of the bZip gene. 
- 	A further requirement was the insertion of a stop codon at the end of the 
bZip gene. This was necessary to ensure that only the bZip sequences 
would be expressed as a fusion protein with -galactosidase upon 
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infection into E. coli. The stop codon sequence used was TAG. This was 
inserted between the bZip sequence and the EcoRI site of the stop primer. 
The final feature of each primer was the inclusion of a 'GC clamp' which 
comprised of GC repeats. This feature added stability to the PCR 
products and also provided an increased region of sequence for the 
binding of the EcoRI restriction enzyme. The GC clamp was placed at the 
5'-end of each primer and removed prior to ligation into XZAPII (Fig.3.3). 
The GCN4 gene. 
The same criteria used for the design of the primers for amplification of 
the bZip gene were applied when determining the sequence of the primers 
for PCR of the GCN4 gene. 
The stop primer was identical to that used for the bZip gene while the 
start primer simply included a sequence which was complementary to the 
start of the GCN4 gene. The sequences 5' to this region were identical to 
those used for the bZip region (Fig.3.3). 
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bZip gene start primer. 
5'- CGCGC GAATTC GGTGCCCGAATCC -3' 
I 	II 	 II 
GC EcoRl bZip 
clamp site sequence 
bZip/GCN4 gene stop primer. 
5'- GCGCGC 
I 	 II 
GAAUC 
II 
TAG CGTTCGCCAAC -3' 
II 
GC EcoRi stop 	bZip 
clamp site codon sequence 
GCN4 gene start primer. 
5'- GCGCGC 




GC EcoRl GCN4 
clamp site sequence 
Fig.3.3. PCR primers. 
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Aid ieGiuSerlhrGluGluVa ISerLeuVaiProSerAsnLeuGluVaiSerlflrThrSer 
TTCTTACCCACTCCIGTTCTAGAAGATGCTAAACTGACTCAAAC&&GAAAGGTTAAGAAACCA 
PheLeuP roth rP roVe IL auG luAspA laLys LeuTh rGinTh rAr 9L yaVa IL y sLysPro 
AATTCAGTCGTTAAGAAGTCACATCATGTTGGAAAGGATGACGAATCGAGACI GGAICATCTA 
AenSer V. IVa ILyiL yeSe nil sHisVa IGIyL ysAspAspG uSe rAr gLeuAspH is Lou 
GGTGTTGTTGCTTAC&AcCGC&AACAGCGTTCGATTCCACTTTCTCCAATTGTGCCCG&ATCC 







Fig.3.4. The YCp88-GCN4 plasmid. 
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3.2.4 Preparation of plasmid DNA. 
Before attempting amplification of the GCN4 and bZip target sequences, 
the plasmid containing the GCN4 gene, YCp88-GCN4, was transformed 
into the E. coli strain JM109 via standard methods 111 ' 118 (Fig.3.4). The 
transformed cells were maintained on ampicillin plates and used to 
amplify the YCp88-GCN4 plasmid DNA. The plasmid DNA was 
linearised prior to each PCR by treating it with the restriction enzyme 
BamHI. Linearising the plasmid DNA in this way minimised the 
possibility of any tertiary structure which could impede the annealing of 
the PCR primers to the DNA. 
3.2.5 The heating cycle. 
The ideal conditions for each of the PCR's were determined by 
experimentation. The reactants were subjected to an initial heating step 
at 900C to ensure complete denaturation of each DNA strand. This step 
was followed by a cycle of denaturation, annealing and extension. A final 
annealing step was also included to stabilise the double-stranded product. 
3.2.6 Results and discussion. 
Agarose gel electrophoresis of the PCR products indicated that each of the 
reactions had been successful. The amplified bZip DNA could be observed 
as a single band at approximately 200 base pairs, and the amplified 
GCN4 gene as a band at 870 base pairs. These sizes compared favourably 
to the calculated size of each fragment. Faint bands at low molecular 
weight corresponding to the PCR primers were also observed. 
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The end-clamps at either end of the amplified genes were removed via 
digestion with the restriction endonuclease EcoRI. The 'sticky-ended' 
EcoRI fragments were separated from the end-clamps on LMP agarose 
gels and each DNA purified from the gel slices. 
The removal of the end-clamps was difficult to monitor as the digested 
and undigested DNA molecules demonstrated extremely similar 
mobilities, even on high percentage agarose gels. A more reliable method 
to generate the sticky-ended molecules would have involved the creation 
of concatemers. This could have been achieved by addition of T4 
polynucleotide kinase to the crude PCR products, resulting in 
phosphorylated molecules. These molecules could then have been ligated 
together with T4 DNA ligase resulting in long concatenated molecules of 
high molecular weight. Subsequent treatment with EcoRI would have 
resulted in sticky-ended molecules all of the same length, but with much 
smaller molecular weight, making the process easier to monitor via 
electrophoresis. 
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3.3 Ligation of the GCN4 and bZip genes into XZAPII. 
3.3.1 Introduction. 
The goals of this project required that the GCN4 and bZip genes be 
inserted into a high efficiency vector such that the genes could be 
selectively expressed and screened for their binding to DNA probes. A 
vector which ideally suited the purpose of the experiments described here 
was XZApII106,116. The XZAPII vector contains a unique EcoRI site 
contained within the lacZ gene into which each gene can be cloned. If the 
gene is cloned within the correct reading frame of the lacZ sequence then 
a fusion protein with f3-galactosidase may be expressed (Fig.3.5). 
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Fig.3.5. The XZAPII vector system. 
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3.3.2 Packaging of lambda. 
Naked bacteriophage X DNA cannot be transformed into cells directly and 
must be packaged with the relevant phage proteins prior to 
transfection 119. In vitro packaging systems have been developed which 
allow efficient packaging of the ?. DNA into phage particles 120,121,122. 
These in vitro packaging systems usually involve the complementation of 
the products of two ?, lysogens, each carrying a single amber mutation in 
a distinctly different gene. Neither of the lysogens is capable of packaging 
phage DNA alone, however, when the extracts are mixed, mature phage 
particles are produced by complementation. The phage particles are then 
able to infect E. coli. 
3.3.3 Transfection of lambda into E. coli. 
The genetics of the ?ZAPII bacteriophage require it to be infected into 
cells which allow correct expression of its genetic elements. The strain of 
E. coli used for initial transfection was XL1-Blue 123. This strain has a 
number of features which make it a suitable host for ?.ZAPII. The F 
episome present in this strain is of particular importance. It allows 
blue/white colour selection for non-recombinant and recombinant phage 
and also 'in vivo excision of the pBluescript SK- phagemid contained 
within the AZAPII genome 106 . 
When XL1-Blue cells containing ?2APII clones are grown in the presence 
of the chromogenic substrate X-gal and the inducer IPTG, the full length 
3-galactosidase gene gives rise to blue colonies. However, if the lacZ gene 
is disrupted by insertion of foreign DNA, growth in the presence of IPTG 
and X-gal results in a white colour due to complementation between the 
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amino-terminal portion of the lacZ gene and the lacZiM15 gene which is 
located on the F episome of XL1-Blue. Therefore, if cells containing the 
XZAPII clones are grown in the presence of IPTG and X-gal, expression of 
the lacZ gene can be monitored by the colour of the bacterial colony. 
Recombinant phage, which have a disrupted lacZ gene, can therefore be 
isolated as white colonies and any blue colonies containing non-
recombinant phage rejected. 
3.3.4 Results and discussion. 
Prior to ligation, the concentration of each of the DNA sequences 
amplified by PCR was determined spectrometrically and adjusted such 
that there was an equimolar ratio of ?2APII arms to insert. An equimolar 
ratio makes it less likely that concatenated species will form during 
ligation. 
Self ligation was avoided by cloning each of the inserts into ?ZAPII arms 
which had been dephosphorylated. T4 DNA ligase will only catalyse the 
formation of a phosphothester bond between adjacent nucleotides if one 
nucleotide contains a 5'-phosphate group and the other a 3'-hydroxyl 
group, therefore the recombinant ?. molecules were nicked. The nicks 
were repaired by E. coli enzymes after transfection. 
Each of the ligation reactions was carried out at 4 0C to avoid disruption 
of the base pairs formed at each EcoRI site. AZAPII clones containing the 
bZip genes were named )bZip, while clones containing the GCN4 gene 
were named AGCN4. 
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3.3.5 Transfection. 
Prior to transfection, each of the XZAPII clones was packaged into 
infectious phage particles using the Gigapack II packaging extract 
(Stratagene). 
After transfection into the E. coli strain XL1-Blue, the efficiency of each 
ligation reaction was checked via blue/white colour selection as described 
above. The cells were grown overnight in the presence of IPTG and X-gal. 
It was necessary to add a high concentration of X-gal because of the large 
polylinker that interrupts the lacZ gene and reduces the complementing 
activity of the lacZ gene with the 1acZAM15 gene. Observation of each 
plate revealed that the efficiency of each of the ligation reactions was 
significantly different. No blue plaques were observed on the agar plate 
containing 2bZip phage, indicating that the bZip gene had been cloned 
into the AZAPII arms with a high degree of efficiency. However, only 75% 
of the plaques grown on the plate containing XGCN4 phage were white. 
This result indicated that the GCN4 DNA had not ligated into the 
lambda arms efficiently. 
The packaging efficiency was monitored via measurement of the plaque 
titre of each sample. The results demonstrated that the ?bZip DNA had 
packaged efficiently (2x10 5 pfu/ml). The GCN4 titre (1.5x10 4 pfuJml), 
however, was substantially lower. This result reflected the fact that the 
GCN4 insert had not been cloned efficiently as recombinant molecules are 
packaged much more efficiently than non-recombinant molecules. 
It was decided on the basis of these results that only the XbZip clones 
should be screened for in vitro binding activity of the 3-galactosidase-bZip 
fusion protein. 
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The purity of the AGCN4 library was investigated by sequencing 
pBluescript DNA derived from white plaques. 
3.3.6 The ?GCN4 library. 
As described above, initial results indicated that the ligation of the GCN4 
gene into XZAPII had not been completely successful. 
A number of white plaques were therefore cored from an agar plate and 
the pBluescript phagemid sequence containing the insert excised from the 
A. phage using Exassist helper phage (see appendix). After transfection 
into SOLR cells, single-stranded phagemid DNA was prepared via 
infection with R408 helper phage. This single-stranded DNA was purified 
and sequenced. 
The results of the dideoxy sequencing showed that none of the samples 
cored from the plate contained A.ZAPII with a GCN4 gene in the correct 
orientation for gene expression. 80% of the phage were shown to contain a 
GCN4 gene which had been cloned upside down, in the wrong orientation 
for gene expression, while the remainder contained no DNA insert at all. 
The reasons for the unidirectional cloning of the GCN4 gene are not clear, 
however, there are a number of possible explanations. It is possible that 
the region of the DNA at the beginning of the GCN4 gene may have been 
folded in such a manner which thsfavoured ligation. It is also possible 
that the foreign DNA sequences of the GCN4 gene were simply not 
tolerated by the lacZ sequences within the multiple cloning site. Indeed, 
this has been shown to occur when cloning foreign DNA into filamentous 
bacteriophage vectors 111 . The unidirectional cloning may also have been 
due to incomplete removal of the GC end-clamp prior to ligation, although 
this is unlikely. 
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The presence of non-recombinants in the phagemid samples derived from 
the white coloured core samples may be attributed to host bacteria which 
have lost the F episome through mutation. Subsequent pBluescript 
phagemids derived from XZAPII were therefore infected into SOLR cells 
and grown on ampicillin/kanamycin plates. This combination of 
antibiotics allowed for selection of both the phagemid and the F episome. 
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3.4 In vitro detection of bZip clones. 
3.4.1 Introduction. 
Previous studies have demonstrated that it is possible to identify DNA-
binding proteins in vitro by screening a library of lambda clones 124 ' 125 . 
The method involves infecting a suitable strain of E. coli with a lambda 
library. The cells are then grown on an agar plate until the bacterial 
plaques are just visible before overlaying the surface of the agar with a 
nitrocellulose filter impregnated with IPTG. The overexpressed fusion 
proteins and cell debris stick to the nitrocellulose. These are then 
screened for their binding characteristics with a radioactively labelled 
DNA probe. Bacterial plaques expressing proteins which bind to the DNA 
probe can subsequently be identified via autoradiography. 
In vitro methods for identifying DNA-binding proteins have a number of 
advantages over in vivo methods and other in vitro techniques: 
The use of radioactively labelled concatenated probes allows 
weakly binding proteins to, be detected more readily. 
Screening of mutants is straight forward. 
No subcloning is required, therefore, identification of clones is 
swift. 
No protein purification is required. 
A large library of mutants can be screened at once. 
3.4.2 The ?bZip library. 
The bZip gene was cloned within the lacZ gene of the bacteriophage 
lambda vector ?2APII as described in section 3.3. This allowed expression 
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of the protein as a fusion with -galactosidase upon induction with IPTG. 
?2APII contains the phagemid sequence pBluscript SK- which can be 
excised in vivo (see appendix). This can be converted to single-stranded 
DNA which can be used for sequencing and in vitro mutagenesis. Any 
'positive' clones can therefore be identified easily and rapidly. 
3.4.3 The DNA probe. 
The process of in vitro screening requires a radioactively labelled DNA 
probe. In this case, two complementary synthetic oligonucleotides 
containing concatenated AP-1 sites were synthesised. The 
oligonucleotides were annealed together and ligated into the phagemid 
vector pTZ19R using standard methods 108 ' 111 (Fig.3.6). The recombinant 
plasmid DNA, pOPi, was transformed into TG1 cells and sequenced to 
ensure correct ligation had occurred. These cells were used for large scale 
preparations of plasmid DNA. The OP1 sequence containing the AP-1 
binding sites was excised via treatment with the relevant restriction 
enzymes. The OP1 DNA was then purified and labelled with the 
appropriate [a- 32P]dNTP. 
Using DNA probes with concatenated binding sites has been shown to 
increase the signal produced upon screening in vitro, therefore, two AP-1 
binding sites were included within the 70bp OP1 probe 124 . An Sf1 site 
was included between each of the AP-1 sites (Fig.3.7). This opened up the 
possibility of inserting DNA sequences between the binding sites should 
the protein be unable to bind due to the close proximity of the AP-1 
binding sites. Cloning the OP1 DNA into pTZ19R allowed the OP1 
fragment to be isolated as a fragment bearing different restriction sites at 
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either end. This allowed the fragment to be labelled preferentially at 
either end of the molecule with various [a- 32P]dNTP's. 
GAATTCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCT1GGC 
Sail 	 SphI LLJrI 	1 
EcoRl 	
'  Sad 	i 	Smal 	 XbaI 	 Pstl 	 Hindill 
Kpnl BamHI 
Fig.3.6. The pTZ19R plasmid. 
106 
AP-1 
5 1- ATTCCACAGTGCCT ATGACTCAT CCAGTGGCCT 
3 t - 	GGTGCTACGGC TACTGAGTA GGTGACCGGA 
AP-]. 
TTTTGGCCCCT ATGACTCAT CCAGTGGGGATCC -3' 
AAAACCGGGGA TACTGAGTA GGTCACCCCTAGG -5 
Fig.3.7. The OP1 probe. 
3.4.4 Screening. 
Before screening with radioactively labelled DNA the plaque titre was 
adjusted such that each of the bacterial plaques was well separated from 
its neighbours on an agar plate. Each of the plates was then incubated in 
the absence of IPTG until the plaques were just visible. The plates were 
removed and nitrocellulose filters impregnated with IPTG laid over the 
developing plaques. The plates were incubated for a further 3-4 hours 
before removing the filters. 
The ideal conditions for the in vitro screening assay were determined by 
experimenting with denaturation and renaturation of the fusion protein 
bound to the nitrocellulose filters. Primary screening was carried out with 
and without denaturationJrenaturation with guanidinium hydrochloride. 
The results indicated that the protein was bound to the nitrocellulose in 
such a way which hampered binding to DNA. Subsequent experiments 
were therefore carried out with denaturation and stepwise renaturation 
of the bound protein. 
The XbZip library was plated in XL1-Blue cells as described above. After 
denaturation/renaturation with guanidinium hydrochloride the filters 
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carrying the fusion proteins were incubated with 32p  labelled OP1 DNA. 
Salmon sperm DNA was also included to act as a control for non-specific 
binding. 
3.4.5 Identification of positive clones. 
After autoradiography approximately 50% of the plaques were visible as 
black dots on a piece of film (Fig.3.8). Each of the positive plaques was 
cored from the agar plate and the phage particles lysed from the agar. 
The pBluescript SK- sequence containing the bZip gene was excised from 
each phage sample using the Exassist helper phage (see appendix). The 
phagemids were then transformed into the E. coli strain SOLR and 
maintained on ampicillin/kanamycin plates. Single-stranded DNA was 
then prepared for sequencing via infection with R408 helper phage. 
Single-stranded rescue of the pBluescript SK- phagemid produces the 
non-coding (-) strand packaged with its coat proteins. 
Before sequencing each of the single stranded DNA samples, a short 
oligonucleotide primer was synthesised. The sequence of the primer was 
chosen such that it annealed to a sequence 102 bases upstream of the 
cloned gene. 
Each of the samples was sequenced using the dideoxy method developed 
by Sanger et a1114 . 
The results of the sequencing experiments showed that all of the single-
stranded DNA samples contained a bZip gene in the correct orientation 
for expression of a f3-galactosidase-bZip protein. These results indicated 
that the screening method used to identify DNA-binding proteins was 
reliable and could be used in future experiments to identify novel DNA-
binding proteins. 
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Fig.3.8. Autoradiograph of in vitro screen. 
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3.5 Overexpression of -galactosidase-bZip fusion protein. 
3.5.1 Introduction. 
Since the bZip DNA had been cloned into a unique EcoRI site within the 
lacZ gene of pBluescript SK-, it was possible to overexpress the bZip 
protein as a fusion with -galactosidase 106. The lacZ gene, which codes 
for -ga1actosidase, is transcribed via induction from the lac promoter. 
The lac promoter is regulated by a helix-turn-helix protein called the lac 
repressor. To abolish the repression of the lac promoter by the repressor 
protein, IPTG, which is an inducer of -galactosidase, may be added to 
the cell extract. IPTG forms a complex with the lac repressor protein thus 
interrupting binding of the protein to the promoter DNA and inducing 
transcription of the lacZ gene. The -galactosidase-bZip fusion protein 
can therefore be produced faster than other cellular proteins simply by 
the addition of IPTG of a suitable concentration (Fig. 3.9). 
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ATG ACC ATG ATT ACG CCA AGC 
met thr met ile thr pro ser 
TCG AAA TTA ACC CTC ACT AAA 
ser lys leu thr leu thr lys 
GGG AAC AAA AGC TGG AGC TCC 
gly asn lys ser trp ser ser 
ACC GCG GTG GCG GCC GCT CTA 
thr ala val ala ala ala leu 
GAA CTA GTG GAT CCC CCG GGC 
glu leu val asp pro pro gly 
TGC AGG AAT TCG 
cys arg asn ser 
GTG CCC GAA TCC AGT GAT CCT 
val pro glu ser ser asp pro 
GCT GCT CTA AAA CGT GCT AGA 
ala ala leu lys arg ala arg 
AAC ACT GAA GCC GCC AGG CGT 
asn thr glu ala ala arg arg 
TCT CGT GCG AGA AAG TTG CAA 
ser arg ala arg lys leu gln 
AGA ATG AAA CAA CTT GAA GAC 
arg met lys gln leu glu asp 
AAG GTT GAA GAA TTG CTT TCG 
lys val glu glu leu leu ser 
AAA AAT TAT CAC TTG GAA AAT 
lys asn tyr his leu glu asn 
GAG GTT GCC AGA TTA AAG AAA 
glu val ala arg leu lys lys 
TTA GTT GGC GAA CGC 
leu val gly glu arg 
Fig.3. 9. -ga1actosidase-bZip fusion protein. 
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3.5.2 Protein overexpression. 
A XZAPII clone containing the bZIP gene in the correct orientation for 
protein expression was identified as described previously and the 
pBluescript SK- phagemid, pbZip, containing the gene excised in vivo. 
After infecting into SOLR cells glycerol stocks of the culture were 
prepared and maintained at -70 0C. 
The overexpression of the fusion protein was investigated initially by 
growing the cells containing the phagemid in the presence of 35S-labelled 
methionine and IPTG. After induction with IPTG aliquots were removed 
from the broth at prescribed time intervals and analysed via SDS-PAGE. 
Autoradiography of the radioactive gel revealed that the correct protein 
was being overexpressed relative to the other cellular proteins and that 
the mass of the protein was approximately MD. This result compared 
favourably with the calculated mass of 11155D. 
Further experiments indentifled the ideal conditions for the growth of the 
cells and induction with IPTG. These conditions were used to prepare 
large amounts of cell free extract containing the overexpressed fusion 
protein. 
3.5.3 Protein purification. 
Partial purification of the bZip fusion was acheived by first lysing the 
cells via sonication and isolating the cell free extract via centrifugation. 
DNA was removed via treatment with DNase I. The protein sample was 
then fractionated with ammonium sulphate. Experiments revealed that 
fractionation of the cell free extract with ammonium sulphate to an 
initial concentration of 40% followed by a 60% step resulted in 
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substantial removal of high molecular weight cellular proteins from the 
extract. 
The relatively small size and poor overexpression of the bZip fusion 
protein excluded various methods which could be used for purification 
from the cell free extract. The initial purification step was therefore 
carried out via size exclusion chromatography using a Sephadex G-50 
column. This allowed separation of the high molecular weight proteins 
from the lower molecular weight proteins (Fig.3.10). However, the major 
drawbacks of this technique were the low resolution, low loading capacity 
of the column and the subsequent dilution of the protein sample. The 
latter problem was overcome by concentrating the filtrate by 
ultrafitration through a 3000 molecular weight cut-off membrane, 
although this method was time consuming due to the low molecular 
weights involved. 
The protein extract was not purified further. However, further 
purification could be achieved by ion-exchange chromatography. The - 
galactosidase-bZip fusion protein is highly basic therefore purification by 
cation-exchange chromatography should be possible. Purification could 
also be achieved via affinity chromatography. However, this method 
would require the construction of an affinity matrix containing DNA 
covalently linked to a suitable support. 
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Fig.3.10. SDS-PAGE gel of protein purification. 
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3.6 Gel retardation assay. 
3.6.1 Introduction. 
A standard method for investigating the binding characteristics of DNA 
binding proteins is the gel retardation assay 126 ' 127 . The technique 
involves incubating a protein sample with a radioactively labelled DNA 
probe containing a binding site and separating the bound complexes from 
the unbound DNA via electrophoresis. DNA molecules with protein bound 
are retarded relative to free DNA molecules due to the increased charge 
and molecular weight of the protein-DNA complex. 
3.6.2 The DNA probe. 
Before carrying out the assay, pOPi DNA was digested with EcoRI and 
XbaI restriction endonucleases. The OP1 fragment was purified and 
labelled preferentially at one end with [a- 32P]CTP by the action of the 
Kienow fragment of DNA polymerase I. 
3.6.3 Characterisation of protein-DNA complexes. 
Partially purified extracts containing the bZip fusion protein were 
incubated with the 32P-labelled DNA probe. Dissociation of protein-DNA 
complexes was minimised by incubating at 40C and separating the 
protein-DNA complexes from the free DNA at high voltage via 
electrophoresis on a native polyacrylamide. 
Initial experiments revealed that the pH of the gel and running buffer 
should be adjusted to pH 7.5 to avoid aggregation of the protein in the 
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wells of the gel. It is likely that the aggregation of the protein in the wells 
was caused by precipitation of cellular proteins in the crude sample. The 
isoelectric point (pI) for the 3-galactosidase-bZip fusion protein was 
calculated as 10.9 and it is therefore likely that the precipitation of the 
fusion protein may have been caused by aggregated cellular proteins at 
pH 8.3, the original pH of the electrophoresis buffer. Experiments also 
showed that the mobility of the fusion protein was sufficiently different to 
that of the probe to retard the DNA. If the mobility of the protein was too 
near to that of the free DNA then no retardation would have been 
observed. 
The results of initial gel retardation experiments indicated the bZip 
fusion bound to the OP1 probe with high affinity. It could be observed 
that the occupation of both the AP-1 sites increased as the protein 
concentration was increased (Fig.3.11). However, at high protein 
concentration the band corresponding to the protein-DNA complex was 
promoted relative to that observed at lower protein concentration. The 
reason for this anomalous behaviour is not clear. The promoted band is 
likely to correspond to OP1 bound by two protein thmers. The binding of 
two protein dimers to the DNA probe would result in increased positive 
charge and size which, under the conditions of the experiment, would be 
expected to lead to increased retardation of the DNA probe. The increased 
mobility of the protein-DNA band may therefore reflect bending of the 
DNA which may have occurred as a result of the binding of two fusion 
protein dimers. Each of the retarded bands could be distinguished by 




increasing protein concentration 
Fig.3.11. Gel retardation assay. 
3.6.4 The DNA-binding affinity. 
Gel retardation assays can be used to obtain an estimate of the DNA-
binding constant of a protein. This is achieved by estimating the 
concentration of protein at which half the DNA is bound.. The estimation 
is only valid if the DNA concentration is at least 10 to 100-fold lower than 
that of the protein 127 . 
The concentration of the fusion protein extract was adjusted such that a 
wide range of concentrations were obtained. The protein samples were 
incubated with OP1 probe DNA and the complexes separated from 
unbound DNA via electrophoresis. 
The binding constant, Kd, was estimated as Ca. 10 10M from an 
auroradiogram which showed that the concentration of protein required 
to bind half the DNA was approximately 2. 12x10'°M. This calculation 
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was based on the assumption that both AP-1 binding sites were 
independent of each other and that there was no cooperativity between 
proteins bound to each site. The estimated value for the DNA-binding 
constant of the fusion protein compared favourably with that calculated 
previously for the binding of GCN4 to the his3 site (10 -10M)84 . 
It must be stressed that the calculated value for Kd was only an estimate 
and its accuracy was dependent upon the measurement of protein 
concentration. The crude protein concentration was ascertained by 
Bradford's assay and the concentration of 3-galactosidase-bZip fusion 
protein in the crude mixture estimated from SDS-PAGE gels. A more 
accurate determination of binding constant would require purification of 
the fusion protein to homogeneity. Accurate quantitation of the amount of 
radioactivity in each of the gel bands would also be required. This could 




It is clear from the experimental work described throughout this chapter 
that ?2APII is an excellent vector for the cloning, identification and 
expression of the cloned bZip gene. 
The results of the in vitro screening process demonstrated that it is 
possible to screen a large library of recombinant phage and identify 
tightly binding proteins. These results indicated that the ?2APII system 
could be used to express a large library of mutants which could be 
screened in an identical manner to that employed for the XbZip library. 
The results also showed that expression of the bZip protein with 3-
galactosidase did not disrupt specific binding of the protein to target 
DNA. 
Cloning of the bZip gene into AZAPII also allowed effective excision of the 
pBluescript SK- phagemid which was used to overexpress the - 
galactosidase-bZip fusion protein. The overexpression, however, was poor 
but may have been improved by addition of a higher concentration of 
IPTG. 
The gel retardation experiments demonstrated that the fusion protein 
ws able to bind to DNA containing tandem AP-1 sites with high affinity. 





4.1 Mutagenesis of GCN4 basic region. 
4.1.1 Background. 
As outlined in Chapter 1, previous studies investigating the binding 
characteristics of mutants of the GCN4 basic region and linker segment 
have been carried out 89 ' 99' 100' 101 . The majority of these studies have 
utilised site-directed mutagenesis to mutate specific residues and have 
focussed mainly on the residues involved in contact with the DNA bases. 
Numerous single and double mutants, which have changed specificity 
have been generated, although the effects of randomly mutating a section 
of the basic region have only been partially investigated. Kim et al used a 
degenerate oligonucleotide with an average of two base-pair substitutions 
to randomise a region between thr-236 and lys-246. Several single and 
double mutants which were able to bind wild-type and symmetrically 
mutated AP-1 sites were isolated 89. The results indicated that residues 
not involved in DNA-base contact could influence specificity in 
combination with other base-contacting residues. 
As yet, a thorough study investigating the effects of mutating a large 
section of the basic region has not been completed. Previous evidence has 
indicated that mutating residues in combination can influence the DNA-
binding specificity of a mutant protein' 0"02' 103 . For example, mutating 
residues on the same face of the basic region helix can alter specificity, 
while other combinations of mutants may also influence specificity 105 . 
Although mutations in the linker segment have been shown to affect 
binding specificity, mutation of basic region residues in combination with 
mutations in the linker segment have not been investigated and these 
may also alter the binding specificity significantly. Mutations in either 
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segment may also distort the basic region a-helix such that the pattern of 
DNA contacts may be changed. The effects of disparate combinations of 
mutations across the basic region and linker segment may also be 
extremely significant in changing the specificity of a mutant protein. It 
would therefore be valuable to randomly mutate a large section of the 
GCN4 basic region. 
Numerous techniques for the generation of random mutations in DNA 
have been devised. These include in vivo methods such as the use of 
mutator strains, in vitro enzymatic approaches, and procedures that use 
chemicals to damage the DNA 128"29"30. However, it is known that 
mutagenesis by these procedures may result in an uneven distribution of 
mutations. A method which ensures complete randomness in the region of 
interest is the spiked oligonucleotide mutagenesis approach3. This 
procedure makes use of the phosphorothioate method for mutagenesis 132 . 
4.1.2 The phosphorothioate method for mutagenesis. 
The phosphorothioate method for oligonucleotide directed mutagenesis of 
DNA overcomes the problems associated with techniques which require 
the transfection of heteroduplex species and which ultimately lead to low 
mutational efficiency 132 . In this procedure, a mismatched oligonucleotide 
primer is synthesised and annealed to a single-stranded DNA template 
containing the gene of interest. The primer DNA is extended by a 
polymerisation reaction in which one of the natural deoxynucleotide 
triphosphates is replaced by the corresponding deoxynucleotide 5'-O-(l-
thiophosphate). Phosphorothioate groups are incorporated into one strand 
of the newly synthesised RF-IV DNA, resulting in a strand asymmetry 
which may be exploited. 
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Certain restriction enzymes cannot hydrolyse a phosphorothioate linkage, 
therefore, reaction of such DNA with a suitable restriction enzyme 
produces a nick in the strand 133"34. The nick in the strand is extended 
into the gap by reaction with a suitable exonuclease which digests away 
the wild-type sequence opposite the mismatch introduced by the primer. 
On repolymerisation, the gapped DNA is repaired using the mutant-
carrying strand as the template. The mutant sequence is now present in 
both strands of the DNA as a fully complementary homoduplex species. 
This DNA can be transfected with high mutational frequencies 132 . 
4.1.3 Spiked mutagenesis. 
The spiked oligonucleotide mutagenesis procedure can be used to 
introduce random mutations across a large region of a gene 
(Fig.4.1) 131 ' 135 . In this method, long oligonucleotide primers which span 
the region of interest are synthesised by a protocol that gives a defined 
probability of incorporating one of the three 'wrong' nucleotide bases at 
each position along the oligonucleotide. The spiked primer is then 
phosphorylated and annealed to a single-stranded DNA template. The 
phosphorothioate procedure for in vitro mutagenesis is then followed and 
a collection of mutants obtained that contain changes spanning the whole 
length of the primer. The mutants can then be transfected into cells and 











C RF IV Repolymerisation 
Mutant HomodupIe 
Fig.4.1. Phosphorotbioate based spiked mutagenesis. 
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4.1.4 Mutagenesis of the GCN4 basic region. 
As mentioned above, no studies have been carried out which have 
subjected- a large section of the GCN4 basic region to random 
mutagenesis. The object of this project was to randomly mutate a large 
area spanning the basic region and linker segment via spiked 
mutagenesis and detect any single, double or triple mutants which bound 
to DNA containing an AP-1 site. Screening of the mutant library in an 
identical manner to that described in Chapter 3 should detect any novel 
mutants, as well as those previously characterised by other procedures. 
It was decided to randomly mutate a segment of the GCN4 bZip gene 
equivalent to the region between arg-234 and asp-255 (Fig.4.2). This area 
covers all residues involved in contacting the DNA bases, as well as the 
majority of those making contacts to the phosphate backbone 59. Residues 
in the linker segment, which comprises the residues between arg-245 and 
asp-255, would also be mutated. These residues have been shown to be 
particularly important in determining half-site preferences 89 . 
230 	235 	240 	245 	250 	255 
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Fig.4.2. The GCN4 basic region and linker segment. 
4.1.5 Design of the mutagenic primer. 
A 76-base spiked oligonucleotide primer corresponding to the region 
between arg-234 and asp-255 was synthesised. The oligonucleotide, which 
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was phosphorylated chemically at the 5'-end, contained two small 5-base 
unspiked regions at the 5'- and 3'-ends to ensure efficient annealing to the 
single stranded template DNA. The 66-base spiked region was 
synthesised such that each primer had a high probability of containing a 
single or double mutation. This was acheived by spiking each 
phosphoramidite used for the synthesis of the oligonucleotide with a 
calculated percentage of the three 'wrong' phosphoramidites. Since a 
binomial distribution is observed for the number of mutations per 
oligonucleotide it was calculated that each phosphoramiclite should be 
spiked with 0.83% of each of the wrong phosphoramidites to maximise the 
number of single and double mutations in each primer molecule. 
The probability P of finding n errors in an rn-long oligonucleotide that is 
synthesised with a fraction a of the three wrong nucleotides at each 
position can be calculated using the following formula' 31 : 
P(n,m,a) = [m!/(mn)!n!][a]fl[1a]TTi 7 
Therefore, the probability of a spiked primer containing one mutation at 
any position is approximately 31%, while the probability of a primer 
containing two mutations is approximately 9%. 
If the population of mutated DNA molecules are transformed efficiently 
then 130000 transformants will cover >99% of the possible one-base 
changes and approximately 30% of the possible two-base changes. 
4.1.6 Mutagenesis. 
The phagemid, pbZip, which contains the bZip region of GCN4 was 
converted to a single-stranded form via infection with a helper phage. (see 
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appendix). The purified (-) strand DNA was then used as a template for 
the spiked mutagenesis procedure. 
The phosphorothioate mutagenesis procedure is a multistep process. The 
first stage of the procedure involves annealing of a mutagenic 
oligonucleotide primer to a single-stranded DNA template. The 
mutagenic strand is then polymerised by the action of Kienow fragment 
and the advancing 3'-end ligated to the 5'-end by the action of T4 DNA 
ligase in the presence of ATP. The template strand is then nicked by a 
suitable restriction enzyme and the template strand digested by the 
action of exonuclease III. The final step of the process involves 
repolymerisation of the template strand with DNA polymerase I. The 
mutated gene can then be excised and cloned into A.ZAPII, allowing 
screening of mutant proteins after transfection into E. coli 
4.1.7 Preparation, of RF-1V DNA. 
Before carrying out the polymerisation step, the concentration of both the 
template DNA and the primer DNA were determined spectrometrically 
and adjusted such that the template:primer ratio was approximately 1:2. 
This ratio was necessary to avoid non-specific annealing which can 
impede polymerisation. The annealing step was then carried out by 
incubating the template/primer mixture successively at 700C,  550C and 
370C to ensure efficient annealing. The ratio of Klenow fragment to T4 
DNA ligase was adjusted to avoid strand displacement synthesis which 
can occur if a large excess of Kienow fragment is present in the reaction 
mixture. This was minimised further by carrying out the reaction at 
16°C. 
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Initial attempts to follow the phosphorothioate method failed at the 
polymerisation stage. Agarose gel electrophoresis of the products revealed 
that the inutagenic primer annealed to the pbZip template efficiently and 
that polymerisation had taken place. However, no ligation occurred as 
indicated by the presence of a strong band corresponding to nicked RF-II 
DNA. Subsequent experiments revealed that the absence of ligation was 
not due to inferior T4 DNA ligase or unsuitable buffer conditions, but was 
likely to be due to the oligonucleotide primer. Since the primer DNA had 
been phosphorylated synthetically, it was thought that the absence of 
ligation may have been due to inefficient phosphorylation. However, 
attempts to rephosphorylate the primer DNA with T4 polynucleotide 
kinase proved unsuccessful. 
Attempts to purify the oligonucleotide by denaturing polyacrylamide gel 
electrophoresis revealed that the DNA was highly impure and consisted 
of numerous smaller fragments. The presence of these fragments may 
have been due to truncated failure sequences or as a consequence of DNA 
degradation which may have been caused by the presence of harmful 
chemical impurities. The failure sequences present in the DNA mixture 
may have been removed by HPLC if the oligonucleotide had not been 
phosphorylated, however, phosphorylated oligonucleotides cannot be 
purified in this manner. It was decided, therefore, to discard the 
oligonucleotide primer and synthesise a fresh, highly purified one. 
The new primer was synthesised with an identical sequence to that used 
previously. In this case the phosphorylated DNA was purified via 
capillary electrophoresis. The DNA was stored in aliquots at 20 0C and 
all manipulations carried out under sterile conditions to avoid any 
biological contamination. 
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The annealing and polymerisation reactions were carried out in an 
identical manner to those above. Agarose electrophoresis of the products 
revealed that the polymerisation reaction had proceeded with high 
efficiency and that approximately 80% of the DNA was present as closed 
circular RF-W DNA. 
4.1.8 Strand specific nicking of RF-IV DNA. 
The second stage of the phosphorothioate procedure for mutagenesis 
involves the nicking of the template DNA strand. The pbZip phagemid 
sequence contains six Ncil restriction sites at positions outwith that 
covered by the mutagenic primer. It was therefore decided to nick the (-) 
strand with the NciI enzyme 136. After incubation in the presence of the 
enzyme, agarose gel electrophoresis revealed that a single band 
corresponding to nicked RF-II DNA was present and that the reaction 
had gone to completion. 
4.1.9 The gapping reaction. 
The penultimate stage of the mutagenesis procedure involves digestion of 
the nicked (-) strand by a suitable exonuclease 137. Exonuclease III is an 
enzyme which digests a free 3'-terminus in the 3' to 5' direction and was 
ideal for the purpose of these experiments. Initial attempts at the 
gapping reaction indicated that the exonuclease III was unable to digest 
the nicked DNA strand. Exonuclease III is known to be very sensitive to 
buffer conditions, therefore, the reaction was attempted in a number of 
different buffers. However, despite varying the buffer conditions no 
gapping of the (-) strand could be observed. 
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Test experiments in a variety of buffers revealed that linear plasmid 
derived DNA could be digested completely over a period of 3 hours, 
indicating that the enzyme used was active and that the inactivity of the 
enzyme in the mutagenesis procedure must have been due to an inhibitor 
present in the nicked DNA mixture. Purification of the nicked DNA by a 
variety of methods failed to improve the efficiency of the reaction, 
therefore, T7 exonuclease, which is more tolerant to variations in buffer 
concentration was used. 
Initial results of reaction with T7 exonuclease indicated that the nicked 
DNA had been digested relatively efficiently. However, subsequent 
attempts to generate RF-IV DNA via polymerisation of the mutagenic 
primer proved impossible, despite identical reaction conditions to those 
used previously. 
The purity of the primer DNA was therefore checked by labelling the 5'-
end with [y- 32P]ATP via incubation with T4 polynucleotide kinase. 
Denaturing polyacrylamide electrophoresis revealed that the primer DNA 
had undergone decomposition into several smaller fragments. The reason 
for this is unclear as the DNA was stored at 200C  in small aliquots. It is 
likely that the degradation of the DNA was a result of destructive 
impurities present in the storage buffer. These impurities may also have 
been responsible for inhibiting the action of exonuclease III in the 
gapping reaction. 
It was decided to attempt the mutagenesis procedure with a third 
mutagenic primer which was not chemically phosphorylated. In this case, 
the primer sequence was not identical to that of the previous two. 
Financial constraints meant that a shorter completely random primer, 
spanning the region between ala-233 and met-250, be synthesised. 
Although this primer was shorter than the previous two, the area of the 
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basic region mediating DNA contact as well as part of the linker segment 
were covered by the primer. 
Before carrying out the polymerisation an aliquot of the oligonucleotide 
primer was labelled at the 5'-end with [y.32P]ATP  as above. Denaturing 
polyacrylamide electrophoresis revealed that the DNA was pure and 
could be observed as a single band after autoradiography. 
Prior to attempting the polymerisation stage, the spiked primer was 
phosphorylated by the action of T4 polynucleotide kinase in the presence 
of ATP. The polymerisation reaction was then carried out in an identical 
manner to that used previously. However, agarose gel electrophoresis 
revealed that no RF-IV DNA had been produced. A band at high 
molecular weight could be observed indicating that strand displacement 
synthesis may have occurred (Fig.4.3). It is unlikely that this was caused 
by an excess of primer DNA as the concentration of both primer and 
template were adjusted to avoid this. 
5 1 
trand anneal primer 	 polymerisation CO) 
Fig.4.3. Strand displacement synthesis. 
Further experiments investigating the reason for the lack of 
polymerisation suggested that the template DNA was responsible. The 
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single-stranded template DNA was therefore sequenced to check for the 
presence of mutations which may have led to incorrect annealing. The 
dideoxy sequencing experiment revealed that a deletion of two guanines 
in the centre of the region covered by the spiked primer had occurred (see 
appendix). The presence of this deletion in the single-stranded template 
would disrupt the annealing of the primer such that an overhang would 
be created. Subsequent polymerisation of the primer partially annealed to 
the mutated template DNA would, therefore, result in strand 
diplacement synthesis making ligation of 3'- and 5'-ends impossible. 
Although sequencing of the single-stranded pbZip template revealed that 
a deletion in the bZip gene had occurred, the question remained as to 
whether this had resulted before or after infection of the cells containing 
the phagemid with helper phage. The cells from a glycerol stock were 
therefore plated and used to prepare a large scale culture of pbZip double-
stranded DNA. The double-stranded DNA was sequenced using the 
dideoxy method which revealed that exactly the same deletion of two 
guanines in the centre of the basic region had occurred. 
The reliability of the phosphorothioate procedure as a technique for in 
vitro mutagenesis was evaluated by carrying out test reactions using a 
control template and primer from an in vitro mutagenesis kit. Each step 
of the procedure was monitored by agarose electrophoresis which 
demonstrated that the procedure was reliable and efficient. 
Other methods for generating the mutant library were considered, and 
these are discussed below. However, financial and time constraints 
precluded the implementation of these procedures. 
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4.1.10 Alternative procedures for mutagenesis. 
Two viable alternative methods of generating the random mutants were 
considered. The first of these involved the reclomng of the entire GCN4 
bZip gene into pBluescript SK-. This could be acheived by first treating 
the pbZip phagemid DNA with EcoRI restriction enzyme which would 
excise the pbZip gene. The phagemid DNA could then be separated from 
the bZip DNA on a LMP agarose gel and the pBluescript phagemid DNA 
purified. The bZip gene, isolated previously by PCR, could then be ligated 
into the phagemid and transformed into SOLR cells. After sequencing to 
isolate a correct clone the spiked mutagenesis procedure could be followed 
as described above. 
A second possibility of generating the random mutations involves cloning 
of the spiked primer DNA as a cassette into the pbZip phagemid (Fig.4.4). 
Computer analysis of the bZip region DNA sequence revealed that two 
unique restriction sites, BbsI and BfaI, not found in pBluescript SK- were 
present. Closer analysis revealed that the BfaI site lay within the region 
covered by the spiked primer, while the BbsI site was 3' to the spiked 
region. 
133 





3.cut with Bfal 
spiked cassette 
Step 2. Ligation of spiked cassette. 
mutagenic region 
BfaI 
Usl 1.ligate spiked DNA  so 	pbZ!p 
2.1igate BbsI linker 	(D 
Fig.4.4. Cassette mutagenesis of pbZip. 
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This method for creating mutants relies on the spiked primer being 
converted to a double-stranded form before ligation. This could be 
achieved via mutually primed synthesis using a DNA primer which 
anneals to approximately 15 bases at the 3'-end of the primer. The BfaI 
site could be created by digestion with BfaI restriction enzyme and the 
double-stranded spiked fragment ligated into pbZip which had been 
digested with BfaI and BbsI. A double stranded linker segment would 
also have to be included in the ligation reaction to fill in the gap 
produced. The recombinant plasmid containing the mutated region could 
then be treated with EcoRI and XhoI to excise the mutated bZip gene. 
After purification this could be cloned into ?ZAPII and the mutants 
screened for their ability to bind DNA probes in vitro. 
In addition to the time involved, this procedure has a number of 
disadvantages associated with it. The random nature of a 15-base 
segment corresponding to residues 245 to 250 will be lost. Also, cloning 
such small DNA fragments may be difficult and inefficient leading to a 
reduction in the mutational frequency. Finally, the BfaI site in the spiked 
primer may be difficult to cut due to the small amount of sequence at this 
end of the primer. 
Numerous other procedures to mutate DNA have been developed. 
However, relatively few of these techniques allow for random mutation 
across a large region of DNA. Two viable alternatives to the 
phosphorothioate method do exist. 
The first of these techniques makes use of PCR and the concept of overlap 
extension for introducing mutations into a region of a gene 
(Fig.4.5) 138"39. The procedure requires the synthesis of four 
oligonucleotide primers; two mutagenic primers which cover the region of 
interest, and two non-random primers which complement either end of 
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the gene. Three separate PCR steps are then carried out with the final 
reaction producing the mutated gene. The gene is excised with the 
relevant restriction enzymes and cloned into the appropriate vector. 
This method would be ideal for the mutagenesis of the GCN4 basic 
region. After carrying out the PCR steps the mutated gene could be 
excised via treatment with EcoRI and XhoI. The DNA fragment could 
then be directionally cloned into AZAPII and the mutants screened. 
A second method for the generation of random mutations involves the use 
of enzymes 140. The procedure requires transformation of the phagemid 
containing the gene of interest into a dut- ung- strain of E. coli which 
allows production of uracil-containing single-stranded DNA. A DNA 
primer is then annealed upstream of the region to be mutated and four 
separate polymerisation reactions carried out, each with a limiting 
concentration of one of the four natural dNTP's. This step generates 
truncated fragments and is followed by a misincorporation step in which 
the three wrong bases are incorporated via polymerisation with reverse 
transcriptase. The mismatched plasmid library is then transformed into a 
dut ung strain of E. coli. 
This method has numerous disadvantages associated with it which makes 
it unsuitable for the mutagenesis of the GCN4 basic region. Firstly, only 
single mutations can be generated. Secondly, the length of the mutagenic 
region cannot be controlled. Finally, the procedure requires re-
transformation and a subsequent cloning step which would reduce the 
number of mutants significantly. 
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Fig.4.5. The overlap extension method for mutagenesis. 
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4.1.11 Future work. 
Assuming the random mutations in the GCN4 basic region have been 
created the next stage of the project would involve cloning of the mutant 
DNA library into XZAPII. This could be acheived by directionally cloning 
into XZAPII arms which had been previously digested with EcoRI and 
XhoI. However, it may be necessary to 'rescue' the DNA prior to cloning 
by transforming the pbZIP mutant library into SOLR cells. This is 
dependent upon the ability of EcoRI and XhoI to hydrolyse 
phosphorothioate linkages. The mutant (+) strand contains only one 
phosphorothioate base, namely dCTPaS. Since EcoRI hydrolyses the 
linkage between guanine and thymine, the plasmid will be linearised. 
However, XhoI hydrolyses the linkage between cytosine and thymine. It 
is therefore possible that only the (-) strand will be nicked making direct 
cloning imposssible and rescue necessary. If this occurs then the 
mutational efficiency may be reduced significantly. The mutational 
efficiency of the procedure can be monitored readliy by sequencing 10-20 
phagemids derived from the XZAPII library. 
Once the mutant DNA library has been cloned into XZAPII screening 
with radioactive DNA probes containing the AP-1 site can proceed. The 
ideal conditions for these experiments have been determined previously. 
Care must be taken in adjusting the plaque titre such that the maximum 
number of single and double mutants can be screened. If we assume a 
high mutational efficiency then screening 130000 plaques should cover 
99% of all single mutations and 30% of all double mutations (see section 
4.1.5). 
Identification and characterisation of mutants should be acheived 
initially by screening with DNA containing with the wild-type AP-1 site. 
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However, subsequent screening experiments should involve incubation 
with symmetrically mutated AP-1 probes as well as a probe containing 
the ATF/CREB site to detect any mutants with altered half-site 
specificity. 
Prior' to further characterisation of mutant proteins they should be 
overexpressed in E. coli as described previously. However, previous work 
has suggested that efficient overexpression may be difficult to acheive 
making purification difficult. An alternative to overexpression would 
involve production of the mutant proteins via in vitro translation. 
pBluescript SK- contains T7 and T3 polymerase binding sites which flank 
the cloned gene. These can be used to produce RNA transcripts from 
which protein can be translated in vitro. This method would therefore 
produce pure protein which could also be labelled in vitro using S-
methionine. 
The binding of mutant proteins should be investigated further via gel 
retardation assay. These should be carried out with a range of DNA 
probes and the binding constant calculated. 
Characterisation of protein-DNA interactions could be acheived by 
modelling studies. The X-ray structure of the GCN4-AP-1 complex has 
been solved and this could be modified accordingly to model interactions 
between DNA bases and amino acid side-chains. Modelling studies may 
provide valuable information which could simplify the rules for DNA-
binding of a bZip protein. 
Finally, a succesful conclusion to this work could lead to the investigation 
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APPENDIX 
pBluescript SK- phagemids. 
The XZAPII vector which was used to express oligonucleotide libraries, 
contains the phagemid sequence pBluescript SK-. This sequence is placed 
between the initiation and termination signals of the LI origin of 
replication and can be excised in vivo. The pBluescript SK- phagemid 
containing the gene of interest can then be used to overexpress protein 
and also to generate single-stranded DNA. Single-stranded phagemid 
DNA was generated continuously during the course of this project for use 
in dideoxy sequencing and in vitro mutagenesis experiments. 
In vivo excision of pBluescript SK- phagemids. 
When XL1-Blue cells are infected with XZAPII, the pBluescript SK-
sequence may be isolated as a phagemid. Since AZAPII contains an fl 
origin of replication derived from a filamentous phage, infection with 
such a phage results in excision of the pBluescript phagemid from the X 
vector. When cells containing ?2APII are infected by the filamentous 
phage, the phage is immediately converted to a double-stranded molecule 
that expresses phage proteins. The filamentous phage gene II protein 
recognises the LI initiator signal and nicks the DNA strand. This nick is 
used as an initiation site for DNA synthesis and replication proceeds from 
this origin, displacing the (+) strand which is cleaved at the termination 
signal. Following nicking by the gene II protein at the termination site, 
the two ends of the single-stranded DNA are ligated to form a circular 
stranded of the (+) strand genome. Because both the filamentous helper 
phage and pBluescript contain the LI phage packaging sequences, both 
molecules can be packaged into filamentous phage particles. 
11 
The recovery of the pBluescript phagemid is performed by heat 
inactivating the E. coli and temperature sensitive 7. phage paticles, 
infecting a fresh culture of E. coli cells at low filamentous phage-to-cell 
ration and plating on ampicilhin plates to select for the ampicillin 
resistant colonies containing the pBluescript phagemid. 
The subsequent transformation of the excised phagemid is performed 
using Su - , X resistant E. coli cells (SOLR) which are plated on ampicillin 
resistant plates. In this strain neither the X phage nor the infecting 
helper phage is active because the cell is resistant to A phage infection 
and the amber mutations for filamentous phage infection are not 
suppressed. The pBluescript phagemid survives in this strain due to the 
presence of the ColE 1 origin and ampicilhin resistance. 
Single-stranded rescue of pBluescript phagemids. 
pBluescript phagemid vectors do not enter the single-stranded state 
unless filamentous helper phage proteins are present. The presence of the 
fl origin within phagemid vectors permits production of single-stranded 
DNA and phagemid particles when required. 
The ft origin in pBluescript contains all the cis-acting sequences required 
for packaging and replication of filamentous phage. All protein factors 
required in trans are supplied, by helper phage infection of E. coli 
harbouring the pBluescript clone. On infection with helper phage, gene II 
is expressed by the helper phage and this promotes single-stranded 
replication of the pBluescript clone at the ft origin. This single-stranded 
DNA is packaged by structural proteins also coded for by the filamentous 
helper phage and extruded, as are the helper phage, through the bacterial 
membrane into the growth medium. The lacZ coding strand is packaged 
III 
by the fl(+) origin and the non-coding strand is packaged from vectors 
containing the fl(-) origin. 
To obtain single-stranded DNA it is essential to grow the clone in ,a strain 
of E. coli containing the F episome coding for pu, because the 





PCR primer 575P 
5'-CGCGCGAATTCGGTGCCCGAATCC-3' 
PCR primer 576P 
5'-GCGGCGAATTCTAGCGTTCGTTCGCCAAC-3' 
PCR primer 120X 
5'-CGCGCGAATTCGATGTCCGAATATCAG-3' 
Spiked primer 1 
5'-GTGCTAGAAACACTGAAGCCGCCAGGCGTTCTCGTGCGAG 
AAAGTTGCAAAGAATGAAACAACTTGAAGACAAGGT- 3' 
Note: underlined sequences are unspiked. 




Mutation of pbZip. 
The autoradiograph depicted below shows the location of the deletion 
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